Volume 6; Issue supp-S3

Main
European Neuropsychopharmacology
Volume 6; Issue supp-S3

European Neuropsychopharmacology

Volume 6; Issue supp-S3

1

L-1-1 - New observations in the life course of unipolar major depression: Risk factors & Treatment goals

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

2

O-1-1 - Radiotelemetry: A model for measuring precipitated and spontaneous lorazepam withdrawal

E. Elliot, J. White

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

3

O-1-2 - Alcoholism and liver enzymes

P. Marković, L. Poleksić, K. Lazarević

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

4

O-1-3 - The ambulatory monitor — An objective method of alcohol withdrawal assessment in humans

R.E. Humeniuk, J.M. White

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

5

O-1-4 - Double-blind comparative trial with carbamazepine vs diazepam treatment of alcohol withdrawal

Ö.A. Kalyoncu, M. Beyazyürek, L. Kuru, R. Solukçu, Ü. Yazman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

6

O-1-5 - Pharmacotherapy of alcoholism: Effects of clinically evaluated compounds in a rat model of alcoholism

J. De Vry, R. Schreiber, J. Smith, R. de Beun

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

7

O-1-6 - The influence of selected quinolones on central action of ethyl alcohol in laboratory animals

J. Strzelec, E. Czarnecka, B. Pietrzak

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

8

O-1-7 - Use of benzodiazepines in opiate addicted patients — Results of an inquiry in basle

D. Ladewig, H. Simoni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

9

O-1-8 - Cannabis withdrawal syndrome: Laboratory artifact or clinically important?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

10

O-1-9 - Cigarette smoking and mood: The psychological processes which underlie nicotine addiction

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

11

O-1-10 - Effects of cigarette smoking on cerebral circulation in normal adults

K. Nagata, T. Shinohara, S. Matsuoka, I. Kanno, E.F. Domino

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

12

O-2-1 - Are genetic influences shared across drug categories? Evidence from a twin study

M.T. Tsuang, M.J. Lyons, J. Meyer, S. Eisen, J. Goldberg, W. True

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

13

O-2-2 - CYP2D6 drug interaction potential of four SSRI's using in vivo dextromethorphan

L. Ereshefsky, C.L. Riesenman, Y.W.F. Lam, J. Simpson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

14

O-2-3 - Contributions of cytochrome P450 isozymes to metabolic pathways of haloperidol

R.T. Coutts, J. Fang, G.B. Baker, P.H. Silverstone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

15

O-2-4 - Toxic haloperidol metabolites in human brain

D. Eyles, T. Stedman, J. McGrath, S. Pond

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

16

O-2-5 - Plasma neuroleptic level and clinical effects of nemonapride-factors weakening the correlation

H. Fujimaki, N. Yamaguchi, Y. Morokawa, M. Kamimura, A. Kosaka, T. Ohta, H. Watanabe, Y. Nagatu, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

17

O-2-6 - Plasma levels of clozapine and norclozapine in chronic schizophrenics

M.C. Mauri, E. Giuliani, M.T. Coppola, A. Sicaro, S. Bravin, G. Invernizzi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

18

O-2-7 - Postmortem concentrations of clozapine and desmethylclozapine in two coronial cases

I.M. McIntyre, P. Fayle, A.K. Olumbe, O.H. Drummer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

19

O-2-8 - Inhibition of clomipramine metabolism by fluvoxamine (In vivo and In vitro data)

S. Haertter, T. Bornemann, M. Arand, F. Oesch, C. Hiemke

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

20

O-2-9 - Plasma concentrations of trans-10-hydroxy metabolites have relation with clinical effects of amitriptyline in depression

T. Someya, K. Shimoda, S. Yasuda, S. Morita, M. Shibasaki, S. Takahashi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

21

O-2-10 - Plasma levels of sertraline and the clinical response

Vinod Kumar, Vivian Garcia, David Loewenstein

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

22

O-3-1 - Prevalence of depressive symptoms in the elderly, a community study

A. Kørner, L. Lauritzen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

23

O-3-2 - Biological abnormalities in depression in the elderly

S. Dahabra, B. Moore, H. Ashton, M. Bahrainian, R. Marsh, I.N. Ferrier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

24

O-3-3 - Outcome of depression in elderly patients changed from tricyclic and other antidepressants to fluoxetine

C. McWilliam, M. Hanna

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

25

O-3-4 - Cardiac tolerability of trimipramine in the elderly

C. Malsch, K. Jäger, B. Schwalb, W. Fischer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

26

O-3-5 - The depression-anxiety syndrome in dementia

A. Wallin, I. Karlsson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

27

O-3-6 - Effects of electroconvulsive therapy on cognitive function in geriatric patients with depression

T. Ohta, Y. Morokawa, H. Watanabe, N. Yamaguchi, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

28

O-3-8 - Sleep and psychotropic drug consumption: Relationships with aging

M.M. Ohayon, M. Caulet, P. Lemoine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

29

O-3-9 - Pharmacological profile of GV150526A a novel glycine antagonist for stroke

E. Ratti, G. Gaviraghi, C. Pietra, D. Trist, A. Reggiani

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

30

O-3-10 - Is paroxetine in post-stroke depression useful?

G. Rutigliano, F. Vadruccio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

31

O-4-1 - Natural killer cell activity and in vitro responsiveness to glucocorticoids and cytokines in the elderly and in Alzheimer's Disease

L. Ravizza, G. Griot, R.G. Masera, P. Prolo, M. Mantovan, A. Staurenghi, L. Tarenzi, A. Lazzero, A. Angeli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

32

O-4-2 - Longitudinal course of immune changes in severe depression

I. Hickie, D. Silove, D. Wakefield, A. Lloyd, B. Bennett

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

33

O-4-3 - The effects of potentiation with lithium of antidepressant drugs on immunological indices in refractory depression

A. Sluzewska, J.K. Rybakowski, M. Sobieska, A. Suwalska, K. Wiktorowicz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

34

O-4-4 - T-cells and NK-cells in schizophrenia: Comparison before and during neuroleptic therapy

N. Müller, J. Primbs, M. Hadjamu, A. Putz, R. Gruber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

35

O-4-5 - Are immunological alterations in schizophrenia due to psychopharmacological treatment?

Barbara Sperner-Unterweger, Carl Miller, Alexandra Witworth, Jörg Kemmler, Margit Gassner, Wolfgang Eisterer, Josef Taler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

36

O-4-6 - Effect of cadmium on immune function and lymphocyte calcium homeostasis

Bin Xue, Zhan Liu, Zhiming Lei, Xian Zhang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

37

O-4-7 - In vitro and in vivo effects of anxiety and benzodiazepines on immune parameters and lymphocyte benzodiazepine receptor mRNA

P. Rocca, A.M. Beoni, P. Ferrero, C. Eva, L. Ravizza

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 282 KB

english, 1996

38

O-5-1 - Bipolar mixed Illness

A. Marneros, A. Rohde, A. Deister

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

39

O-5-2 - Mania secondary to HIV infection

S. Ellen, A. Mijch, A. Cockram, S. Crowe, F. Judd

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

40

O-5-3 - Pharmacological treatment of mania (The use of code-HD)

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

41

O-5-4 - Renal function after 20 years of lithium therapy

R. Walker, G. Burrows, I. Schweitzer, D. Grounds, B. Davies

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

42

O-5-5 - Superiorlty of lithium over verapamil in mania: A randomized controlled trial

Shirley A. Walton, Michael Berk, Shlomo Brook

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

43

O-5-6 - Baseline hypermetabolism may predict carbamazepine response, and hypometabolism nimodipine response in mood disorders

T.A. Ketter, T.A. Kimbrell, M.S. George, R.M. Stein, M.W. Willis, B.E. Benson, M.A. Frye, G. Corá-Locatelli, R.M. Post

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

44

O-5-7 - GH & PRL response to apomorphine in bipolar and unipolar depression

Anne Walsh, Heather McPherson, Trevor Silverstone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

45

O-5-8 - D-fenfluramine-induced prolactin release in bipolar mania

J.H. Thakore, V. O’Keane, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

46

O-5-9 - Factors affecting melatonin sensitivity to light: Relevance for a putative marker of bipolar affective disorder

P.J. Nathan, T.R. Norman, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

47

O-5-10 - Lithium therapy: Some considerations about safety

G. Rutigliano, F. Vadruccio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

48

O-6-1 - The treatment of adolescent depression: Where is the evidence?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

49

O-6-2 - Peculiarities of depressive states in children

T. Chebykina, Z. Curlynd, A. Chustrak, A. Chebykin, V. Gavrichko

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

50

O-6-3 - The use of electroconvulsive therapy in young people

G. Walter, J. Rey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

51

O-6-4 - Sertraline treatment in children and adolescents: Tolerability, efficacy and pharmacokinetics

J. Alderman, R. Wolkow, H. Johnston, M. Rosenthal, J. Ferguson, F. Sallee, J. Blumer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

52

O-6-5 - Risperidone added to methylphenidate in attention deficit hyperactivity disorder

P.V.F. Cosgrove

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 266 KB

english, 1996

53

O-6-6 - Impact of stress-factors of technical accident on emotional sphere of children

A. Chustrak, A. Chebykin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

54

O-6-7 - Prophylactic of emotional stress in schoolchildren

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

55

O-6-8 - Handedness and behavior problems in children

S.K. Min, Y.J. Shin, K.J. Oh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

56

O-6-9 - Role of body build and temperament in children treated because of neurotic disorders

M. Lintsi, J. Liivamiägi, A. Aluoja

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

57

O-7-1 - Eating disorders and diagnostic subtypes: Targeted use of antidepressants

A. Giannelli, F. Lugo, D. Zappulli, L. Codazzi, R. Papa, G. Penati, G. Redaelli, F. Cavagnini

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

58

O-7-2 - The augmented platelet intracellular calcium response to serotonin in anorexia nervosa but not bulimia may be due to subsyndromal depression

Michael Berk, Kamini Kessa, Christopher Paul Szabo, Neil Butkow

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

59

O-7-3 - Pain sensitivity, Alexithymia, and Depression in Patients with eating disorders

M. de Zwaan, D. Biener, M. Bach, S. Wiesnagrotzki, G. Stacher

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

60

O-7-4 - Olfactory sensitivity in eating disorders

Pinkhas Sirota, David Shamir, Edith Mitrany

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

61

O-7-5 - On the possible role of testosterone in serotonin-related psychiatric disorders in Women

E. Eriksson, B. Andersch, L. Bergman, O. Bing, P. Kakaoulidis, C. Sundblad, I. Wikander

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

62

O-7-6 - Antidepressants and breastfeeding

A. Buist, T. Norman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

63

O-7-7 - Postpartum psychoses: Long-term course and outcome

A. Rohde, A. Marneros

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

64

O-7-8 - A review of the nosological status and aetiological theories of postpartum psychosis

T. George, J. Hackwood

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

65

O-8-1 - Comparison of undergraduate and postgraduate psychiatric training in eastern europe

C. Höschl, N. Sartorius, P. Mohr

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

66

O-8-2 - Therapeutic effect of yohimbine in organic and non-organic erectile dysfunction

K. Mann, T. Klingler, J. Röschke, U. Witzsch, O. Benkert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

67

O-8-3 - Does plasma free-MHPG increase in the delirious state?

J. Nakamura, N. Uchimura, S. Yamada, M. Tanaka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

68

O-8-4 - Antiulcer properties of some prolin-containing oligopeptides

G.E. Samonina, M.A. Abramova, I.P. Ashmarin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 282 KB

english, 1996

69

O-8-5 - Betahistine and neuroplasticity in vertigo (Metaanalysis)

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

70

O-8-6 - Treatment of anxiety disorders in rheumatic heart disease

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

71

O-8-7 - Mental disorders in rheumati heart disease

E. Grigoryeva, A. Khokhlov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

72

O-8-8 - Peer review system accepted for three year hospital accreditation

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

73

O-8-9 - Epilepsy in forensic psychiatry

A.F. Joubert, P.H.J.J. vRensburg, C.A. Gagiano, T. Verschoor

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

74

O-8-10 - Further studies with marine compound NIO-50

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

75

O-8-11 - Negative priming in high schizotypes, psychosis and after ketamine

D. Healy, F. Watson, G. Harborne, S. Tipper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

76

S-1-1 - The need for faster and more effective antidepressants

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

77

S-1-2 - Augmentation of antidepressant effects with 5HT-1A antagonists. Basic and clinical studies

F. Artigas, L. Romero, V. Pérez, E. Alvarez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

78

S-1-3 - The 5-HT1A receptor antagonist WAY-100635 enhances the behavioural effects of SSRIs

C.T. Dourish, C. McNicoll, A. Fletcher

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

79

S-1-4 - Present and future tools to improve the antidepressant response based on the differential properties of 5-HT receptor subtypes

P. Blier, R. Bergeron, C. de Montigny

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

80

S-1-5 - Double-blind study on the effect of pindolol addition to accelerate the antidepressant response

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

81

S-2-1 - Stabilizing action of partial dopamine receptor agonists in psychosis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

82

S-2-2 - The development of (−)-3PPP as an Antipsychotic drug

Carol A. Tamminga, Adrienne C. Lahti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

83

S-2-3 - Neuroimaging to evaluate atypical antipsychotic compounds: An FDG pet study of SDZ MAR 327

S. Potkin, J. Wu, R. Anand, R. Bera, D. Carreon, R. Hartman, D. Keator

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 282 KB

english, 1996

84

S-2-4 - Preclinical pharmacology of dopamine partial agonists

L. Meltzer, M. Davis, R. MacKenzie, T. Pugsley, L. Wise, T. Heffner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

85

S-2-5 - Late phase II study of OPC-14597, a dopamine autoreceptor agonist in schizophrenic patients

M. Toru, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

86

S-3-1 - Somatization across different psychopathological states

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

87

S-3-2 - Comorbidity between somatoform disorders and depression

A.C. Altamura, M.G. Carta

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

88

S-3-3 - Assessment of somatic symptoms in depression and somatoform disorders

S. Kasper, A. Neumeister, N. Praschak-Rieder, A. Heiden

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

89

S-3-4 - Depression and somatization: A neurochemical link?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

90

S-3-5 - Psychoimmunological and neuroendocrine findings in depression and somatization

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

91

S-4-1 - Multiple amyloidogenic pathways in Alzheimer's disease — Which is the therapeutic target?

Colin L. Masters, Konrad Beyreuther

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 270 KB

english, 1996

92

S-4-2 - Abnormal homeostasis of pH and Zinc: The prelude for cerebral Aβ amyloid formation?

A.I. Bush, C.S. Atwood, X. Huang, R.D. Moir, C.G. Glabe, R.E. Tanzi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

93

S-4-4 - Pharamaceutical research and development activities in Alzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

94

S-5-1 - NPY increases in rat brain following electro-convulsive seizures: An animal model for the Working action of ECT

T.G. Bolwig, J.D. Mikkelsen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

95

S-5-2 - Genes and the mechanism of action of ECT: Focus on 5-HT1A receptors

R. Segman, S. Shoham, R. Ebstein, B. Lerer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

96

S-5-3 - Peripheral and endocrine measures of ECT'S effects: Relation to side effects and outcome

D. Nutt, J. Smith, K. Williams, S. Wilson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 268 KB

english, 1996

97

S-5-4 - Medication resistance, ECT response and relapse prevention

H.A. Sackeim, J. Prudic, R.F. Haskett, B. Mulsant, H. Pettinati

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

98

S-5-5 - ECT: Relationships among therapeutic outcome, amnesia, and EEG response

R.D. Weiner, A.D. Krystal, C.E. Coffey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

99

S-6-1 - Preclinical models of aggressive behavior: The role of serotonin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

100

S-6-2 - Individual differences in 5-HT1A receptors and aggressive behavior in monkeys

M. Raleigh, D. Nielsen, D. Goldman, M. Linnoila, M. McGuire

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

101

S-6-3 - Molecular genetics of suicidal behavior

J.J. Mann, K.M. Malone, D.L. Nielsen, D. Goldman, J. Erdos, J. Gelernter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

102

S-6-4 - Serotonergic targets for the pharmacotherapy of aggression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

103

S-7-1 - The diagnosis, course, biological and neuropathological correlates of HIV neurocognitive disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

104

S-7-2 - Pathogenesis of the aids dementia complex in the SIV model

N.E.J. Berman, J.K. Johnson, L. Raymond, E.B. Stephens, S. Joag, O. Narayan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

105

S-7-3 - Animal models for neuroaids

F.E. Bloom, J. Elder, H. Fox, L. Gold, S.J. Henriksen, T. Phillips

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

106

S-7-4 - Current progress in developing rodent models of HIV/CNS disease

L. Vitkovic, A.S. Basile, Y. Sei

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

107

S-7-5 - Monocyte transit across the blood-brain barrier in AIDS: A role for adhesion molecules and chemokines

W.D. Lyman, S.A. Downie, J.W. Berman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

108

S-8-1 - State-dependent regulation of neuronal excitability by dopamine

D.J. Surmeier, S.T. Kitai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

109

S-8-2 - Dopamine D2 receptors in the ventral striatum: Multiple effects or receptor subtypes?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

110

S-8-3 - D2 receptor activation in distinct striatal neurons in comparison with D3 receptors

M. Sasa, K. Ishihara, T. Amano, H. SasMatsubayashi, T. Momiyama, N. Todo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

111

S-8-4 - D2 dopamine receptors in the short- and long-term modulation of corticostriatal transmission

P. Calabresi, A. Pisani, D. Centonze, M. De Murtas, G. Bernardi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

112

S-8-5 - Cholinergic and GABAergic interneurons in the striatum

Y. Kawaguchi, T. Aosaki, Y. Kubota

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

113

S-8-6 - Do ‘D2-like’ dopamine receptors mediate neuronal excitation or inhibition: Some functional-behavioural implications

J.L. Waddington

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

114

S-9-1 - Developing new antipsychotic drugs and treatment strategies: An overview

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

115

S-9-2 - Immediate early gene expression and the mechanisms of action of atypical antipsychotics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

116

S-9-3 - Pharmacological genetic association studies and clozapine response

R. Kerwin, D. Collier, S. Shaikh, M. Arranz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

117

S-9-4 - Treatment and consequences of relapse in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

118

S-9-5 - Contemporary and anticipated approaches to the reduction of antipsychotic induced side effects

W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

119

S-9-6 - Psychosocial interventions in schizophrenia: Partnership into the 21st century

Nicholas Tarrier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

120

S-10-1 - Subthreshold anxiety and depression disorders: Prevalence rates and needs for treatment

W. Maier, J.P. Lépine, P. Franke, O. Weiffenbach, M. Gänsicke

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 269 KB

english, 1996

121

S-10-3 - Efficacy of pharmacological treatment in short term anxiety

P. Boyer, J.C. Bisserbe, M. Patay, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

122

S-10-4 - Social phobia: Defining thresholds for treatment intervention

E. Weiller, J.C. Bisserbe, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

123

S-10-5 - Psychotropic drugs use in patients with anxious or depressive disorders vs subthreshold syndromes

J.C. Bisserbe, E. Weiller, P. Boyer, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

124

S-11-1 - Familial patterns of comorbidity of migraine and mood disorders

K.R. Merikangas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

125

S-11-2 - Affective disorders & headache syndromes in the community

J. Angst, K.R. Merikangas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 273 KB

english, 1996

126

S-11-3 - Pleomorphic expressions of bipolarity

Hagop S. Akiskal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

127

S-11-4 - Valproate in migraine prophylaxis

Ninan T. Mathew

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

128

S-11-5 - The bipolar nature of migrainous psychopathology

J. Himlelhoch, K.R. Merikangas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

129

S-12-1 - Typical vs. Atypical antipsychotics in late-life psychosis

D.V. Jeste, J.H. Eastham, J.P. Lacro, D. Naimark, E. Rockwell

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

130

S-12-2 - Atypical neuroleptics: Pharmacologic considerations

R.S. Sweet, B.G. Pollock, B.H. Mulsant, J. Rosen, R. Henteleff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

131

S-12-3 - Serotonin-dopamine antagonists in elderly schizophrenics

S. Yamawaki, T. Hayashi, N. Yokota, T. Takahashi, G. Sato, Y. Tahara

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

132

S-12-4 - Risperidone for visual hallucinations in the elderly

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

133

S-12-5 - Atypical neuroleptics in older monkeys

Daniel E. Casey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

134

S-13-1 - Ontogeny of behavioural responses to psychostimulants in rodents

E. Alleva, F. Cirulli, G. Laviola

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

135

S-13-2 - The role of NMDA systems in the developmental neurobehavioral toxicity of phencyclidine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 295 KB

english, 1996

136

S-13-3 - Neurophysiological effects of drugs of abuse on dopamine neurons in vitro during development

G. Mereu, A. DeMuro, V. Lilliu, W. Francesconi, F. Berton, A. Casula, S. Vicini, G.L. Gessa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

137

S-13-4 - Developmental neuro- and immunotoxicity of benzodiazepines

M. Schlumpf, A.R. Salili, A.A. Schreiber, B. Bürgi, E.E. Bütikofer, H. van Loveren, W. Lichtensteiger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

138

S-13-5 - Neurobehavioral changes produced by prenatal exposure to carbon monoxide, a constituent of cigarette smoke

V. Cuomo, R. Cagiano, M.A. De Salvia, G. Renna, I. Cortese, G. Siro, V. Di Giovanni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

139

S-14-1 - Cholinergic therapy directed at cognitive deficits

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

140

S-14-2 - Muscarinic partial agonists in the symptomatic treatment of Alzheimer's Disease

R. Kumar, E. Cedar, M. Clark, J. Loudon, J. McCafferty, L. Hammond

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

141

S-14-4 - Therapeutic strategies directed at the non-cholinergic transmitter systems

P.H. Robert, V. Aubin-Brunet, C.H. Beau, V. Migneco, G. Darcourt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

142

S-14-5 - GABA-B receptors in memory processes

W. Fröstl, S. Mickel, C. Mondadori, H. Olpe, H. Bittiger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

143

S-15-1 - Cognitive disorders in HIV infection

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

144

S-15-2 - The mechanisms and clinical relevance of HIV associated brain damage

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

145

S-15-3 - NMR spectroscopy as a tool for in vivo detection and monitoring of progress of HIV CNS disease

G. Fein, D. Meyerhoff, M. Weiner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

146

S-15-4 - The epidemiology of psychiatric disorders in HIV infection: Depression, mania and dementia

C.G. Lyketsos, G.J. Treisman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

147

S-15-5 - Treatment of neuropsychiatric disorders associated with HIV and AIDS

G.J. Treisman, M. Fishman, P.R. McHugh, C.G. Lyketsos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

148

S-16-1 - Neuropeptides in human sleep regulation

A. Steiger, I. Antonijevic, S. Bohlhalter, R-M. Frieboes, T. Schier, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

149

S-16-2 - Benzodiazepines versus newer hypnotics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

150

S-16-3 - GABA mechanisms in sleep deprivation and their relevance to depression

E. Holsboer-Trachsler, U. Hemmeter, E. Seifritz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

151

S-16-4 - Cholinergic mechanisms in sleep and depression

Berger Mathias, Hohagen Fritz, Riemann Dieter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

152

S-16-5 - SSRIS, TCAS and augmentation therapies — Exploring mechanisms by acute and chronic sleep effects

S.J. Wilson, C.J. Bell, N.J. Coupland, D.J. Nutt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

153

S-17-1 - Will novel antipsychotics be the next standard of care for patients with schizophrenia: A worldwide report on risperidone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

154

S-17-2 - First episode psychosis: Diagnosis, treatment and the role of new antipsychotics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

155

S-17-3 - SDA antipsychotics — from theory to clinical practice: Lessons from PET neuroimaging

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

156

S-17-4 - Clinical experience of novel antipsychotics the role of novel antipsychotics for the many phases of schizophrenia

Nicholas A. Keks

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

157

S-17-5 - Managing elderly patients with psychotic and behavioural disturbances in dementia

Sanford I. Finkel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 275 KB

english, 1996

158

S-18-1 - The role of the suprachiasmatic nuclei (SCN) as a biological clock: Effects of melatoninergic substances

F.W. Turek, O. Van Reeth

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

159

S-18-2 - Animal models of circadian disorders and their treatment with chronobiotics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

160

S-18-3 - Sleep and mood disorders: Relationship to circadian rhythms

T.A. Wehr, E. Leibenluft, P.J. Schwartz, E.H. Turner, N.E. Rosenthal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

161

S-18-4 - Does bright light treatment for winter depression work better than a placebo?

C.I. Eastman, M.A. Young, L.F. Fogg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

162

S-18-5 - Circadian phase disorders and psychiatry

A. Lewy, V. Bauer, R. Hughes, N. Cutler, R. Sack

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

163

P-1-1 - Long term outcome of fluoxetine treatment in elderly depressed patients

C. McWilliam, M. Hanna

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

164

P-1-2 - Clinical efficacy of paroxetin on old age depression

W. Wittgens, K. Beine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

165

P-1-3 - Inter-observer reliability among GPs in a controlled clinical study on geriatric depression

L. Lauritzen, A. Kørner, T. Pedersen, L. Bayer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

166

P-1-4 - Comparison of sertraline and fluoxetine in depressed geriatric outpatients: Plasma levels and efficacy

P. Newhouse, G. Ko, E. Richter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 137 KB

english, 1996

167

P-1-5 - Effect of gender, age and smoking on doses and plasma levels of neuroleptics in schizophrenia

R.K.R. Salokangas, T. Taiminen, E. Syvälahti, S. Saarijärvi, H. Lehto, H. Niemi, V. Ahola

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

168

P-1-6 - Age effect on the plasma levels of various psychotropic drugs

M. Kamimura, N. Yamaguchi, Y. Morokawa, T. Ohata, H. Fujimaki, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

169

P-1-7 - Effect of age, gender and food on the pharmacokinetics of flesinoxan

J. Van Harten, C. Boon, W. Strobel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

170

P-1-8 - Sertraline and nortriptyline: Heart rate, cognitive improvement and quality of life in depressed elderly

W. McEntee, G. Ko, E. Richter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

171

P-1-9 - No age-related change in platelet tritiated paroxetine binding in humans

D. Marazziti, L. Palego, L. Dell’Osso, M. Fancelli, A. Rossi, A. Lucacchini, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

172

P-2-1 - Lack of pharmacokinetic interaction between buspirone and haloperidol in schizophrenic patients

M.W. Jann, H.F. Huang, T.P. Chang, J.S. Chen, D.J. Juang, S.K. Lin, Y.W.F. Lam, C.P. Chien, W.H. Chang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

173

P-2-2 - Effect of rifampin on plasma concentrations and clinical responses of haloperidol in schizophrenics

J.I. Woo, Y.H. Kim, J.C. Shim, J.G. Shin, S.G. Shin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

174

P-2-3 - The quantitative analysis of a haloperidol derivative and its neurotoxic metabolites in baboons

K. Avent, C. Van der Schyf, D. Eyles, N. Castagnoli, S. Pond

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

175

P-2-4 - Mitochondrial toxicity of haloperidol and its metabolites

H.R. McLennan, M. Degli Esposti, J.J. McGrath, S.M. Pond

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

176

P-2-5 - Multiple dose pharmacokinetics and dose proportionality study of ‘Seroquel’ (ICI 204,636) in male schizophrenic patients

Y.W.J. Wong, B.J. Ewing, L.F. Fabre, P.T. Thyrum, C. Yeh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

177

P-2-6 - The effect of ziprasidone on steady-state pharmacokinetics of a combined oral contraceptive

G.J. Muirhead, P.R. Holt, S. Oliver, J. Harness, R.J. Anziano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

178

P-2-7 - Single and multiple dose pharmacokinetics of ziprasidone in healthy males

K.D. Wilner, R.A. Hansen, A.C. Johnson, J.J. Miceli, G. Apseloff, N. Gerber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

179

P-2-8 - The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium

K.D. Wilner, R.J. Anziano, T.G. Tensfeldt, S.M. Pelletier, G. Apseloff, N. Gerber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 139 KB

english, 1996

180

P-2-9 - Specific HPLC method for risperidone and 9-hydroxy risperidone therapeutic monitoring

E.A. Balant-Gorgia, L.P. Balant

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 272 KB

english, 1996

181

P-2-10 - Reversible metabolism of clozapine and clozapine N-oxide

W.H. Chang, S.K. Lin, H.Y. Lane, F.C. Wei, W.H. Hu, Y.W.F. Lang, M.W. Jann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

182

P-2-11 - Kinetics/dynamics of midazolam and two new benzodiazepines during first administration in man. I: RO 48-6791

J. Dingemanse, G. Roncari, H.C. Schoemaker, A.F. Cohen, J.M.A. Van Gerven

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

183

P-2-12 - Kinetics/dynamics of midazolam and two new benzodiazepines during first administration in man. II: RO 48-8684

J.M.A. Van Gerven, G. Roncari, H.C. Schoemaker, A.F. Cohen, J. Dingemanse

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

184

P-2-13 - Low kinetic interaction potential of flesinoxan in man

J. Van Harten, S. May, C. Baedeker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

185

P-2-14 - No kinetic or dynamic interaction between flesinoxan and fluoxetine

J. Van Harten, K. Wesnes, W. Strobel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

186

P-2-15 - The influence of morning and evening dosing on the pharmacokinetics of flesinoxan

J. Van Harten, M.A.R. Bosschaert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

187

P-2-16 - Sumatriptan in plasma by HPLC with coulometric detection; effect of paroxetine treatment on plasma sumatriptan concentrations

M. Franklin, J. Odontiadis, E.M. Clement, P.J. Cowen, Y.K. Wing

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

188

P-2-17 - Sertraline and P4503A3/4

A. Harvey, S. Preskorn, R. Lane, K. Wilner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

189

P-2-18 - Multiple dose pharmacokinetics of sertraline in subjects with varying degrees of hepatic impairment

Keith D. Wilner, Greg Everson, George H. Foulds, Robert A. Hansen, Roshan Shrestra, Carol McKinley, Craig J. McClain

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

190

P-2-19 - Multiple dose pharmacokinetics of sertraline in subjects with varying degrees of renal impairment

Keith D. Wilner, Barbara A. Baris, George H. Foulds, Rich J. Anziano, Thomas Berl, Michael G. Ziegler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

191

P-2-20 - Safety and pharmacokinetics of sertraline in Japanese subjects

K. Kamijima, H. Miyaoka, A. Iwanami, C. Tadokoro, T. Otsubo, S. Oyamada

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

192

P-2-21 - Pharmacokinetic profile of mirtazapine

C. Timmer, G. Voortman, L. Delbressine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

193

P-2-22 - Amitriptyline and nortriptyline: Are plasma levels after first dose predictive for therapeutical efficacy?

C.H. Stuppaeck, A.B. Whitworth, W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

194

P-2-23 - Clomipramine and obsessive-compulsive disorder: Serum levels and outcome

C. Gorenstein, T. Marcourakis, M. Bernik, F. Lotufo-Neto

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

195

P-2-24 - Clomipramine and Panic Disorder: Serum levels and clinical improvement

T. Marcourakis, C. Gorenstein, R.T. Ramos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

196

P-2-25 - Paroxetine and fluoxetine plasma concentrations and CYP2D6 inhibition

Y.W.F. Lam, C.L. Riesenman, L. Ereshefsky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

197

P-2-26 - SSRIs and inhibition of the cytochrome P4502D6 isoenzyme

A. Harvey, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

198

P-2-27 - Cytochrome P-450 isozymes and N-demethylation of citalopram enantiomers in vitro: Clinical significance?

B. Rochat, M. Amey, M. Gillet, P. Raumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

199

P-2-28 - Concentrations of the enantiomers of trimipramine and its metabolites in CYP2D6 and CYP2C19 phenotyped patients

C.B. Eap, L. Koeb, M. Amey, P. Baumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

200

P-2-29 - Plasma alpha-one acid glycoprotein (AAG) and halo-peridol (H) concentrations in schizophrenic patients

B.G. Augustin, M.W. Jann, B.L. Crabtree, W.M. Pitts, J.G. Carter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

201

P-3-1 - An association study between the ADH2 gene, the ALDH2 gene and alcoholism

Y. Kono, H. Yoneda, H. Imamichi, T. Sakai, A. Uchida, K. Suzuki, Y. Mizoi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

202

P-3-2 - 5-HT1A receptors, alcoholism and suicidal behavior

W. Pitchot, M. Ansseau, A. Gonzalez Moreno, M. Hansenne

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

203

P-3-3 - Risperdal reduces alcohol use in dual disabeld schizophrenia patients

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

204

P-3-4 - Acamprosate in the relapse prevention of alcohol dependence

A.B. Whitworth, W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

205

P-3-5 - Adrenal gland enlargement resulting from hyperactivity of the pituitary-adrenocortical system in alcoholics

Y. Ida, I. Shirao, S. Tsujimaru

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

206

P-3-6 - Treatment of alcohol withdrawal delirium and changes in monoamine

N. Uchimura, J. Nakamura, Y. Tsuchiyama, Y. Nakazawa, S. Yamada, H. Ohshima, M. Oshima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

207

P-3-7 - Acamprosate effect on changes of transferrin levels in ethanol preferring and non-preferring rats

P. Mikołajczak, I. Okulicz-Kozaryn, E. Kamińska, M. Sobieska

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

208

P-3-10 - Glycine/NMDA antagonists reduce amphetamine disruptions in prepulse inhibition in the rat

L.J. Bristow, G.P. Cook, K.L. Saywell

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

209

P-3-11 - Blockade of brain serotoninergic receptors deteriorates amphetamine-induced self-stimulation in rats with lesion of medial prefrontal cortex

Sergei G. Varavka, Peter D. Shabanov, Andrei A. Lebedev

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

210

P-3-12 - Effects of ritanserin on methamphetamine-induced sensitization

T. Tanaka, S. Watanabe, M. Suzuki, E. Nagata, H. Wakatabe, J. Ishigooka, M. Murasaki, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

211

P-3-13 - Decrease in calmoduin mRNA level of rat hippocampus after repeated methamphetamine treatment

Y. Shimizu, K. Akiyama, T. Ishihara, Y. Fujiwara, S. Kuroda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

212

P-3-14 - Effect of behavioral sensitization of amphetamine on schedule-induced polydipsia (SIP) in rats

C.S. Tung, N.K. Huang, T.H. Yin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

213

P-3-15 - Ecstasy (MDMA): Mood effects in recreational polydrug users

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

214

P-3-16 - 5-HT uptake inhibitors attenuate the neurochemical effects of 3,4 methylenedioxymethamphetamine

A.J. Harkin, J.P. Kelly, B.E. Leonard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

215

P-3-17 - Chronic treatment with sulpiride enhances NMDA-induced Ca2+ influx in cultured rat cortical neurons

T. Hayashi, A. Kagaya, N. Yokota, T. Oyamada, M. Takebayashi, M. Furutani, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

216

P-3-18 - Sedative effect of acamprosate and its influence on chosen memory tasks in two different aged rats

I. Okulicz-Kozaryn, P. Mikołajczak, E. Kamińska, K. Szczawińska

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

217

P-4-1 - Mirtazapine vs tricyclic antidepressants: An overview of efficacy data

A. Sitsen, C. Kremer, H. Slinning

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

218

P-4-2 - Mirtazapine vs tricyclic antidepressants in the treatment of severely depressed patients

M. Zivkov, A. Mühring

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

219

P-4-3 - Efficacy of mirtazapien vs clomipramine in severely depressed, hospitalized patients

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

220

P-4-4 - Safety of mirtazapine in overdose

M. Zivkov, C.M.E. Kremer, M. Hoes

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

221

P-4-5 - Treatment with mirtazapine is not related to complaints of sexual dysfunction

H. Rekers, C. Kremer, M. Zivkov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

222

P-4-6 - Mirtazapine lacks typical SSRI-related adverse effects

R. Rekers, C. Kremer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

223

P-4-7 - Efficacy of mirtazapine in moderate and severe depression

R. Pinder, C. Kremer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

224

P-4-8 - Patterns of mood improvement with mirtazapine

C.M.E. Kremer, M. Zivkov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

225

P-4-9 - Nefazodone vs. Sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction

R.K. Shrivastava, A. Feiger, Ari Kiev, P.G. Wisselink

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

226

P-4-10 - Efficacy of nefazodone versus placebo in a double-blind trial of depressed inpatients

J. Feighner, M. Bennett, D. Roberts, F. D’Amico, K. O’Brien

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

227

P-4-11 - Double-blind comparison of milnacipran and imipramine in depressive patients

R. Matsubara, I. Onodera, K. Ito, F. Okada, Y. Asano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

228

P-4-12 - Comparative study of moclobemide & clomipramine in the treatment of mild forms of depression

M. Krsmanović, Č. Miljević, M. Jašović, C. Crnobarić

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

229

P-4-13 - Sulpiride Augmentation in refractory depression

Ž. Stanković, D. Živković-Milovanović, D. Bugarski-Kirola, A. Damjanović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

230

P-4-14 - Efficacy of combined lithium/TCAs and Lithium/SSRIs therapy in major depressive disorder

I. Timotijević, M. Zdravković, B. Miljković, M. Pokrajac

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

231

P-4-15 - Combined cognitive-behavioral and pharmacotherapy in refractory depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

232

P-4-16 - Gepirone extended release (ER) treatment of outpatients with major depression — A dose response study

C. Cohn, L. Fabre

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

233

P-4-17 - Cortisol synthesis inhibition: A new treatment strategy for depression

J.H. Thakore, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

234

P-4-18 - Antidepressive properties of indeloxazine hydrochloride, a cerebral activator

M. Yamamoto, M. Suzuki, T. Yamaguchi, Y. Ozawa, T. Yamaguchi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

235

P-4-19 - First open study with new antidepressant LY248686 (duloxetine) for depression in Japan

J. Ishigooka, M. Murasaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

236

P-4-20 - Predictors of outcome for long-term treatment

R.M.A. Hirschfeld

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

237

P-4-21 - Serotonergic dysregulation in dysthymia

M. Steiner, E. Dunn, M. Coote, G. Browne

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

238

P-4-22 - A randomized, double-blind placebo-controlled study: Venlafaxine ER capsules in major depression

A. Derivan, L. Aguiar, R. Rudolph, R. Entsuah

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

239

P-5-1 - Effects of chronic administration of fluvoxamine on extracellular levels of serotonin in the rat hippocampus in vivo

O. Tajima, K. Nara, N. Sasaki, S. Murata, M. Kogure, K. Takemasa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 296 KB

english, 1996

240

P-5-2 - Multiple 5-HT receptor subtypes regulate [3H]5-HT release in terminal projection areas: Superfusion studies in rat and mice brain

G. Piñeyro, R. Hen, P. Blier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

241

P-5-3 - Effect of a combination of befloxatone and a 5HT1A receptor antagonist on rat cortical serotonin release

O. Curet, J. Lourdelet, G. Damoiseau, P. Avenet, H. Depoortere, B. Scatton

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

242

P-5-4 - Anti-aggressive effects of alnespirone (S-20499), a potent 5-HT1A receptor agonist, in wild-type rats

M. Lesourd, E. Mocaër, S.F. De Boer, J.M. Koolhaas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

243

P-5-5 - Electrophysiological effect of alnespirone (5-20499) on the rat locus coeruleus — Comparison with buspirone

P. Schmitt, F. Soulière, E. Mocaër, M. Lesourd, G. Chouvet

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

244

P-5-6 - Effects of alnespirone (S 20499) in the depression model (Unavoidable Aversive Light Stimulus Test) in rats

M. Messaoudi, A. Tricoire, P.H. Jung, D. Desor, E. Mocaër, M. Lesourd

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

245

P-5-7 - Effect of the potential anxiolytic drug (+) S-20499 in the olfactory bulbectomised rat model

C. McGrath, T. Norman, G. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

246

P-5-8 - Behavior-enhancing effects of 5HT1A agonists and 5HT2 antagonists on a Progressive Ratio schedule

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

247

P-5-9 - Chirality and the SSRIS

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

248

P-5-10 - (+)-Mirtazapine and (+)-desmethylmirtazapine levels in rat brain in relation to in vivo blockade of α2 receptors

C.L.E. Broekkamp, L.P.C. Delbressine, H.W. Rijk, C.G. Van De Vorstenbosch

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

249

P-5-11 - Mirtazapine stimulus properties reveal indirect 5-HT1A receptor activation

H.H.G. Berendsen, C.L.E. Broekkamp

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

250

P-5-12 - The neurochemical and behavioural effects of the isomers of mirtazapine in normal rats

C. McGrath, T. Norman, G. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

251

P-5-13 - Effect of chronic antidepressant treatment in the olfactory bulbectomised rat model of depression

C. McGrath, T. Norman, G. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

252

P-5-14 - Effect of nicotine treatment, pre- and post surgery, on the behaviour of the olfactory bulbectomised rat

C. McGrath, T. Norman, G. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

253

P-5-15 - Sertraline did not affect monoamine receptors and adenylate cyclase activity in rat brain

C. Tadokoro, Y. Kiuchi, A. Ota, K. Oguchi, K. Kamijima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

254

P-5-16 - Endogenous mono-ADP-ribosylation in the hippocampus of amygdaloid kindled rat

K. Suzuki, H. Iwasa, S. Kikuchi, T. Sato, N. Morinaga, M. Noda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

255

P-5-17 - Importance of protein synthesis for the development of chemical kindling

G. Grecksch, A. Becker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

256

P-5-18 - Effects of verapamil and ethaverine on the behavioral despair test in rats

Y.H. Kim, S.K. Lee, J.H. Kim, T.M. Gang, K.T. Kim

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

257

P-5-19 - Antidepressant-like effects of the I2 ligands idazoxan and 2-BFI in the rat porsolt test

H.C. Jackson, S. Jordan, S.L. Handley, N.R. Mirza, D.J. Nutt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

258

P-5-20 - L deprenyl versus moclobemide in animal model of depression — “swim test”

C.D. Milijeć, D. Djorgović, A. Damjanović, C. Cmobarić, V.R. Paunović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

259

P-5-21 - Effects of mirtazapine and other clinically active antidepressants in the DRL-72

J.S. Andrews, S. Bloks, J.H.M. Jansen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

260

P-5-22 - Effects of selective antidepressants on the sensitivity of central adrenergic receptors

T. Babinski, S. Totic, D. Marinkovic, V.R. Paunovic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

261

P-5-23 - Tricycles and SSRIS enhance adenylate cyclase and cAMP-related behaviors in rat

H. Maeda, H. Ozawa, H. Kamata, S. Toki, S. Saito, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

262

P-5-24 - A comparison of phenelzine and its N-acetylated analogue in the elevated plus-maze test

G.B. Baker, D. Treit, T.M. Paslawski, M. George, R.T. Coutts

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

263

P-5-25 - HT-90B, a putative anxiolytic with potent antidepressive activity

T. Miyauchi, K. Inagawa, H. Uchida, C. Takashima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

264

P-5-26 - The effect of lithium potentiation of antidepressants in chronic mild stress model of depression in rats

A. Sluzewska, K. Szczawinska

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

265

P-5-27 - Increase of GABA-B responses by carbamazepine as a mechanism of action in affective disorders

J. von Wegerer, J. Walden

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

266

P-6-1 - Behavioural & cognitive effects of stimulant & non stimulant drugs in childhood attention deficit disorder

A. Orgill, S. Serfontein

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

267

P-6-2 - Exploratory eye movements in child patients with mental disorders

E. Matsushima, T. Ohkura, H. Ichikawa, S. Yamada, M. Takamizawa, A. Nakane, M. Toru

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

268

P-6-3 - Body satisfaction in a group of obese adolescents

A. Morosin, E. Molinari, P. Ragazzoni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

269

P-6-4 - Satisfaction with life, anxiety and eating attitude in a sample of obese women

P. Ragazzoni, E. Molinari, A. Morosin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

270

P-6-5 - Serotonin-induced platelet calcium response in eating disorders

Y. Okamoto, A. Kagaya, A. Kugaya, Y. Uchitomi, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

271

P-6-6 - Menstrual cycle effects in women with premenstrual syndrome

S. Evans, M. Haney, F. Levin, R. Foltin, M. Fischman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

272

P-6-7 - Maprotiline for depression during menopause: A philippine menopause clinic experience

E. Obillo, J. Eleazar, J. Demeterio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

273

P-6-8 - Cortisol and maternal attraction to infant odour

M. Steiner, M. Coote, A. Tran, C. Corter, A. Fleming

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

274

P-6-9 - Establishing a liaison network service for postnatal depression in the primary care setting

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

275

P-7-1 - The course of primary and secondary negative symptoms in a controlled trial with olanzaplne

Gary D. Tollefson, Todd M. Sanger, Charles M. Beasley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

276

P-7-2 - Olanzaplne versus placebo, results of the United-States double-blind olanzapine trial

C. Beasley, P. Tran, W. Satterlee, G. Tollefson, Y. Lu, A. Kuntz, P. Bradley, S. Paul

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

277

P-7-3 - Acute and long-term results of the dose ranging double-blind olanzapine trial

P. Tran, C. Beasley, G. Tollefson, A. Crawford, M. Dellva, S. Gusman, A. Wood

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 301 KB

english, 1996

278

P-7-4 - Acute and long-term results of the North American double-blind olanzapine trial

P. Tran, C. Beasley, G. Tollefson, M. Dellva, S. Hamilton, R. Van Ostrand, S. Paul

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

279

P-7-5 - Olanzapine versus haloperidol: acute results of the multi-center international trial

P. Tran, C. Beasley, J. Street, R. Tamura, M.A. Dellva, K. Graffeo, J. Krueger, G. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

280

P-7-6 - Olanzapine versus haloperidol: Long-term results of the multi-center international trial

C. Beasley, P. Tran, J.N. Beuzen, R. Tamura, M.A. Dellva, J. Bailey, J. Krueger, G. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

281

P-7-7 - Clinical efficacy and safety of olanzapine in Japanese schizophrenics

J. Ishigooka, S. Miura, M. Murasaki, Y. Kudo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

282

P-7-8 - The efficacy of zuclopenthixol acetate in the treatment of psychtic patients

N. Dilbaz, H. Guz, G. Boyam

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

283

P-7-9 - Clinical experience with zuclopentixol in twenty-five acute schizofrenic patients

J. Vilapriño, R. Galeno, S. Kotlik, E. Gris, C. Guzzo, A. Dáneo

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

284

P-7-10 - A controlled double blind study of zuclopenthixol acetate compared with clothiapine in acute psychosis including mania and exacerbation of chronic psychosis

H. Uys, M. Berk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

285

P-7-11 - Efficacy of l-sulpiride in the treatment of disorganization in acutely relapsed schizophrenics

M. Guazzelli, A. Gemignani, P. Pietrini, S. Starnini, A. Bertolino, Al. Bertolino, M. Casacchia, L. Fiori

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

286

P-7-12 - Amisulpride in the treatment of acute schizophrenia: A double-blind comparison with haloperidol

P. Boyer, S. Turjanski, O. Fleurot

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

287

P-7-13 - Amisulpride in the treatment of acute episodes of schizophrenia

A.J. Puech, S. Turjanski, O. Fleurot

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

288

P-7-14 - Efficacy and safety of three doses of sertindole and haldol in schizophrenic patients

C. Tamminga, R. Mack, J. Zborowski, D. Morris, T. Sebree, B. Wallin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

289

P-7-15 - Dose ranging study comparing 4 doses of sertindole and 1 dose of haloperidol in schizophrenic patients

A. Hale, M. van der Burght, H.H. Friberg, A. Wehnert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

290

P-7-16 - Two open-label, long-term safety studies of sertindole

D. Daniel, K. Holgate, T. Sebree, J. Staser, P. Schmitz, B. Wallin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

291

P-7-17 - The ‘organic’ basis of Late-Onset Schizophrenia

P. Sachdev, H. Brodaty, N. Rose, N. Haindl, C. Frayter, P. Kitchener

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

292

P-7-18 - Comorbid mood disturbance in schizophrenia

Gary D. Tollefson, Yili Lu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

293

P-7-19 - Anhedonia and depression in chronic schizophrenia: Distinct or overlapping constructs?

G. Loas, P. Boyer, C. Noisette, A. Legrand

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

294

P-7-20 - The relationship between negative symptoms and depression in schizophrenia

D. Addington, J. Addington

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

295

P-7-21 - Negative symptoms and neuropsychologic dysfunction are independent features of schizophrenia

J. Maltez, M. Guerreiro, F. Cavaglia, A. Matos-Pires, M. Botelho

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

296

P-7-22 - Panic attacks in chronic schizophrenia a complication of long-term antipsychotic medication

H. Higuchi, M. Kamata, M. Yoshimoto, K. Yoshida, Y. Hishikawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

297

P-7-23 - Clozapine in treatment-resistant schizophrenic patients: Clinical, neuropsychological and neuroanatomical correlates of outcome

C.L. Shriqui, L. Annable, G. Bouchard, P. Grondin, M. Dufour

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

298

P-7-24 - Correlations between neurophysiological abnormalities and brain morphological changes in schizophrenia

E. Tanabe, S. Takahashi, M.L. Xia, T. Sakai, M. Matsuura, T. Kojima, E. Matsushima, S. Obayashi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

299

P-7-25 - Impairment of spatial context memory in schizophrenia

J.M. Danion, L. Rizzo, M. Van Der Linden, J.G. Rohmer, D. Grangé

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

300

P-7-26 - Eye movement studies on schizophrenics and their parents

M.L. Xia, S. Takahashi, E. Tanabe, M. Matsuura, T. Kojima, E. Matsushima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

301

P-7-27 - Eye movements made during the performance of a maze test in Schizophrenic patients

H. Ando, E. Matsushima, K. Ando, T. Kojima, Y. Shimazono

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

302

P-7-28 - A checklist for assessment of treatment in schizophrenic syndromes: Interscale validity and interrater reliability

E. LindstrÖm, L. Ekselius, E. Jedenius, A. Almqvist, I.M. Wieselgren

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

303

P-7-29 - Inter-rater reliability of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS)

T. Inada, G. Yagi, G. Gardos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

304

P-7-30 - Neurocognitive subtypes of schizophrenia according to performances at the verbal fluency test

P.H. Robert, S. Thauby, V. Migneco, I. Chaix, M. Benoit, G. Darcourt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

305

P-7-31 - The attribution of intentionality, causality and disposition by deluded patients

D.J. Done, V. Millard, H.A. Pattinson, M. Papanastasiou

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

306

P-7-32 - An inventory of chronic, mentally disabled schizophrenic outpatients

L.K. Flyckt, A. Taube, G.V. Edman, E. Jedenius

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

307

P-7-33 - Serotonin in platelets and whole blood in schizophrenic patients

C.H. Tan, H.S. Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

308

P-7-34 - Risperidone vs. Haloperidol in the treatment of schizophrenia: A meta-analysis comparing their efficacy and safety

I. De Oliveira, A. De Miranda, E. De Sena, E. Pereira, M. Ribeiro, E. Silva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 165 KB

english, 1996

309

L-2-1 - Recent advances in the therapeutics of schizophrenia: Is dopamine still relevant?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

310

L-3-1 - Neuropeptides and their receptors

John B. Furness

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

311

O-9-1 - The role of in vivo amygdala dopamine to cocaine self-administration behavior

Y.L. Hurd, A. McGregor

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

312

O-9-2 - Gamma-hydroxybutyric acid alters intravenous cocaine self-administration in rats

M.C. Martellotta, G. Cossu, L. Fattore, W. Fratta

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

313

O-9-3 - Occupation of D1, D2 and 5HT-2 receptors and behavioural sensitization to cocaine

M.T. Martin-Iverson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

314

O-9-4 - Smoked or I.V. Cocaine binges in humans: Is there a “crash”?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

315

O-9-5 - Determinants of withdrawal in a methadone maintenance population

J.M. White, K.R. Dyer, F. Bochner, A. Menelaou, A.A. Somogyi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

316

O-9-6 - A rapid discontinuation of opiates and benzodiazepines in dependent patients

E.H. Bennie, N. Poole

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

317

O-9-7 - Lofexidine in the treatment of heroin withdrawal — A comparative study with clonidine

S.K. Lin, L.W. Su, C.J. Tsai, W.H. Hu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

318

O-9-8 - Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal in rats

D.P.D. Woldbye, T.G. Bolwig

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

319

O-9-9 - Striatal adenosine-dopamin modulation in morphine dependence and withdrawal

Y.-P. Liu, D.-T. Bau, N.-K. Hwang, P.-M. Chen, W.-J. Liu, C.-S. Tung

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

320

O-9-10 - Clocinnamox inhibits heroin-stimulated nucleus accumbens dopamine overflow

G. Zernig, H.C. Fibiger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

321

O-10-1 - Panic attack as an epi-phenomenon of the phobic-obsessive-compulsive disease

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

322

O-10-2 - Biological and psychipathological comparison of OCD and tourette syndrome

N. Müller, A. Putz, M. Riedel, N. Kathmann, A. Straube

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 283 KB

english, 1996

323

O-10-3 - Fluoxetine treatment of acral lick dermatitis in dogs: A placebo controlled randomised double blind trial

Dora Wynchank, Michael Berk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

324

O-10-4 - Proton magnetic resonance spectroscopy in obsessive compulsive disorder

D. Ebert, O. Speck, A. König, H. Rasche-Räuchle, M. Berger, J. Hennig, F. Hohagen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

325

O-10-5 - Cerebral blood flow and WCST in OCD

J.V. Lucey, C. Burness, D.C. Costa, L.S. Pilowsky, I.M. Marks, P.J. Ell, R.W. Kerwin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

326

O-10-6 - Serotonergic function in obsessive-compulsive disorder

P. Monteleone, F. Catapano, S. Di Martino, M. Maj

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

327

O-10-7 - OCD: Comparisons of SRI treatment

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

328

O-10-8 - Use of citalopram, a serotonin selective reuptake inhibitor, in OCD

D. Stein, C. Maud, M.B. Bouwer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

329

O-11-1 - Long term course of tardive dyskinesia

G. Gardos, J.O. Cole, J.A. Samson, D.S. Haskell, L.A. Boling, C. Waternaux, D. Kovacs

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

330

O-11-2 - Neuroleptic-induced extrapyramidal symptoms: Factor structure

L. Annable, G. Chouinard, A. Ross-Chouinard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

331

O-11-3 - Gates: A new instrument for the clinical and research assessment of neuroleptic-induced movement disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

332

O-11-4 - Informing patients about tardive dyskinesia: A survey of clinicians' attitudes

J.D.E. Laugharne, J. Arcelsus, A. Davies

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

333

O-11-5 - Tardive dyskinesia and ethnicity: Review of the literature

M. Smith, J.R. Swartz, K. Burgoyne, R. Gadasally, J. Ananth

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

334

O-11-6 - Abnormal movements in never medicated Indian schizophrenic patients

R.G. McCreadie, R. Thara

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 264 KB

english, 1996

335

O-11-7 - CYP2D6, genotype, phenotype and tardive dyskinesia

J. Ananth, K.M. Lin, J. Costa, R. Poland

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 138 KB

english, 1996

336

O-11-8 - A phosphoinositide linked dopamine receptor mediates dyskinetic jaw movements in rats

H. Rosengarten, A.J. Friedhoff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 138 KB

english, 1996

337

O-11-9 - A double-blind, assessment of carteolol, in the treatment of neuroleptic-induced akathisia

A. Aoba, M. Murasaki, K. Kamijima, G. Yagi, S. Komemushi, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 138 KB

english, 1996

338

O-12-1 - Is loxapine an ‘atypical’ antipsychotic: A pet study of the in vivo 5-HT2 and D2 occupancy

S. Kapur, G. Remington, C. Jones, S. Houle, R.B. Zipursky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 138 KB

english, 1996

339

O-12-2 - A Positron Emission Tomography (PET) activation study of major depression

P. Chua, P.L.P. Morris, G.F. Egan, M. Saling, A. Pipingas, S.U. Berlangieri, G. Fitt, I. Schweitzer, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

340

O-12-3 - Relationship between D2 receptor occupancy and plasma haloperidol: A pet study

S. Kapur, G. Remington, C. Jones, P. Roy, K. Reed, S. Houle, R.B. Zipursky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

341

O-12-4 - D2-receptor imaging in atypical neuroleptics

S. Kapur, J. Remington, B. Kasper, A. Tauscher, A. Küfferle, C. Barnas, S. Asenbaum, I. Podreka, T. Brücke

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

342

O-12-6 - Petstudies of D1 and D2 dopamine receptors in schizophrenic patients

Y. Okubo, T. Suhara, K. Kobayashi, O. Terasaki, Y. Someya, T. Sassa, Y. Sudo, K. Suzuki, O. Inoue, Y. Tateno, M. Toru

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

343

O-12-7 - A PET study of attention and working memory: Subspecialisation of human prefrontal cortex

B. O’Sullivankubo, M. Large, N. Barrett, F. Karayanidis, P. Michie, G. Smith, J. Watson, D. Kavanagh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 272 KB

english, 1996

344

O-12-8 - Risperidone and the relationship between D2 receptor occupancy and plasma levels

G. Remington, S. Kapur, C. Jones, R. Zipursky, S. Houle

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 133 KB

english, 1996

345

O-12-9 - Time course for dopamine and serotonin receptor occupancy in the brain of schizophrenic patients following dosing with 150 mg ‘seroquel’ TID

O. Gefvert, L.H. Lindstrom, B. Langstrom, M. Bergstrom, T. Lundberg, R.A. Yates

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 133 KB

english, 1996

346

O-13-1 - Sleep and waking during acute histamine H3-agonist BP 2.94 or H3-antagonist carboperamide (MR 16155) administration in rats

J.M. Monti, H. Jantos, A. Ponzoni, D. Monti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 133 KB

english, 1996

347

O-13-2 - Neuropeptide Y inhibits hippocampal seizures and wet dog shakes

D.P.D. Woldbye, J.D. Mikkelsen, T.M. Madsen, P.J. Larsen, T.G. Bolwig

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

348

O-13-3 - Differentiation of classical and novel antipsychotics using animal models

T. Skarsfeldt, J. Arnt, J. Hyttel, C. Snchez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

349

O-13-4 - Kindling of the dorsal and the ventral hippocampus and it's effects on learning performance in rats

A. Becker, K. Letzel, U. Letzel, G. Grecksch

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

350

O-13-5 - Differential effects of mirtazapine and imipramine on cognitive performance in male long evans rats

J.S. Andrews, J.H.M. Jansen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

351

O-13-6 - Protective effects of anapsos in rats with hippocampal neurodegeneration

X.A. Alvarez, J.J. Miguel-Hidalgo, R. Lagares, A. Franco, L. Fernández-Novoa, K. Beyer, J.I. Lao, B. Vecino, J.. Díaz, J.M. Sempere, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

352

O-13-7 - The comparison of lisinopril and captopril activities on cerebral blood flow in SHR rats

T. Bobkiewicz-Kozlowska, R. Forjasz-Grus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

353

O-13-8 - Neuroprotective effects of dopamine receptors agonists in cerebral ischemia

H. Allain, J.M. Reymann, M. O’Neill, M. Caldwell, B.E. Leonard, D. Bentué-Ferrer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

354

O-13-9 - Effects of imidazoline2 receptor ligands on neuronal damage in global ischaemia in the rat

J.A. Graven, E.L. Conway

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

355

O-14-1 - Posttraumatic stress disorders among the afghanistan war veterans

P. Sidorov, M. Lukmanov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

356

O-14-2 - Twenty-four-hour urinary monoamine excretion in posttrumatic stress disorder

Moonyong Chung, IlJin Jeong, MyungHee Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

357

O-14-3 - Influence of psychotropic agents on process of brain desadaptation in emotional stress states

P.A. Nerush, V.V. Koldunov, E.G. Topka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

358

O-14-4 - Regulation of gene expression of catecholamine synthetic enzymes in brain and periphery of rats during stress

R. Kvetnansky, M. Rusnak, S. Zorad, B. Nankova, E.L. Sabban

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

359

O-14-5 - Serotonin metabolism and 5-HT1A receptors in genetically defined fear-induced aggression

N.K. Popova, D.F. Avgustinovich

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

360

O-14-6 - GABA-A receptor mediated antistress activity of neurosteroids in mice

S.K. Kulkarni, D.S. Reddy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

361

O-14-7 - Anticonflict effect of high doses of testosterone in male wistar rats

O. Bing, M. Heilig, P. Kakaoulidis, C. Sundblad, E. Eriksson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

362

O-14-8 - Social isolation increases the effects of paroxetine in the forced swimming test

N. Wongwitdecha, P. Ganpinyo, C. Kasemsook

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

363

O-14-9 - Attenuation of stress induced cortical dopamine neurones by L-701,324, a selective glycine/NMDA antagonist is mediated via an interaction with GABAergic neurones

C.L. Barton, P.H. Hutson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

364

O-14-10 - Antisense studies of rat brain GABAA receptor structure and function in vivo

J. Karle, M. Nielsen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

365

O-15-1 - Suprising drug effects on the circadian rest-activity cycle in schizophrenia

H.-J. Haug, U. Reichert, C. Cajochen, P. Nussbaum, A. Wirz-Justice

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

366

O-15-2 - The effects of ethanol on the circadian rhythms of locomotor activity and body temperature in rats

H. Egami, S. Tsujimaru, Y. Ida

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

367

O-15-3 - Chronobiotic versus hypnotic properties of melatonin

A. Wirz-Justice, S.M. Armstrong

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

368

O-15-4 - Effects of H-CRH on sleep and body temperature rhythms

T. Hirano, N. Uchimura, Y. Tsuchiyama, T. Sakamoto, Y. Hashizume, Y. Nakazawa, T. Kotorii

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

369

O-15-5 - Timed melatonin administration on circadian rhythms and vigilance states

A. Wirz-Justice, C. Cajochen, J. Kräuchi, D. Möri, P. Graw

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

370

O-15-6 - Sleep EEG and nocturnal hormone secretion after traumatic brain injury

A. Steiger, R-M. Frieboes, U. Müller, H. Murck, D.Y. von Cramon, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

371

O-15-7 - Melatonin secretion exhibits tolerance during chronic fluvoxamine treatment in medicated schizophrenic patients

Henry Silver, Igor Barash, Natan Odnopozov, Nabil Jahjahl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

372

O-15-8 - Serotonergic control of melatonin secretion: The role of 5-HT1A receptors

P.J. Nathan, T.R. Norman, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

373

S-19-1 - The assessment of PTSD in veterans

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

374

S-19-2 - Biological paradigms of the attentional processing in post traumatic stress disorder

A.C. McFarlane, R. Clark, D. Weber, C. Galletly

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

375

S-19-3 - Neuroendocrine alterations in PTSD

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

376

S-19-4 - Naloxone reveals decreased threshold for hypothalamic CRH release in PTSD

R. Jackson, G. Hockings, J. Grice, W. Ward, M. Walters, G. Jensen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

377

S-19-5 - The modified dexamethasone suppression test (mDST) in chronic PTSD

M. Hopwood, J. Marcina, T. Norman, P. Morris, I. Schweitzer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

378

S-19-6 - Central noradrenergic and serotonergic neurotransmitter function in chronic PTSD

P. Morris, M. Hopwood, J. Marcina, T. Norman, I. Schweitzer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

379

S-20-1 - Concentration/effect relationships in clinical psychopharmacology: Clinical trials designs

L.P. Balant, E.A. Balant-Gorgia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

380

S-20-2 - Clinical pharmacokinetic update on anticonvulsants

T.A. Ketter, M.A. Frye, A.M. Callahan, L.B. Marangell, R.M. Post

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

381

S-20-3 - Theoretical considerations of dose/concentration/effect relationships: Direct and indirect pharmacokinetic/dynamic models

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

382

S-20-4 - Measurement of lithium brain concentration by Li-7 MRS and correlation with effects

T. Kato, S. Takahashi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

383

S-20-5 - Clinical pharmacokinetics of serotonin reuptake inhibitor and newer antipsychotic drugs

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

384

S-21-1 - Biological predictors of response

D. Marazziti, L. Conti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

385

S-21-2 - Long term treatment of panic disorder-agoraphobia

G. Perugi, L. Musetti, C. Toni, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

386

S-21-3 - Predictors of response in obsessive-compulsive disorder

J. Zohar, Y. Sasson, R. Cohen, I. Iancu, O. Dolberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

387

S-21-4 - Temperament and pharmacological response in depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

388

S-21-5 - Clinical predictions of response to treatments in mood disorders

S.A. Montgomery

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

389

S-22-1 - Consequences of corticosteroid receptor ablation

T.J. Cole, J.A. Blendy, A.P. Monaghan, K. Krieglstein, S. Berger, W. Schmid, K. Unsicker, G. Schütz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

390

S-22-2 - Brain corticosteroid receptors and stress system disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

391

S-22-3 - Regeneration and inactivation of bioactive corticosteroids: Windows for neuro-pharmaceutical intervention

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

392

S-22-4 - Mineralocorticoid receptor mRNA variants in the developing hippocampus: Distribution and regulation

D.M. Vázquez, S.K. Kwak, J.F. López, S.J. Watson, H. Akil

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

393

S-22-5 - Intracerebral antisense oligonucleotides reduce mineralocorticoid-induced ingestive behaviors

R.R. Sakai, L.Y. Ma, S.J. Fluharty

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

394

S-23-1 - Lithium treatment in psychiatry: Early development and recent observations

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

395

S-23-2 - The lithium ion: A foundation for psychopharmacological specificity

J.C. Soares, S. Gershon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

396

S-23-3 - Rapid cycling bipolar disorder: An update

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 273 KB

english, 1996

397

S-23-4 - Lithium in comparison to valproate and carbamazepine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

398

S-24-1 - Important factors in long-term maintenance therapy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

399

S-24-2 - Medication choices in maintenance antipsychotic therapy: Theory and clinical practice

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

400

S-24-3 - Long-term use of novel antipsychotics side-effects, safety and the risks of non-compliance

Nicholas A. Keks

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

401

S-24-4 - Clinical experience of relapse prevention with novel antipsychotics in chronic schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 267 KB

english, 1996

402

S-24-5 - Aiding resocialisation of the complaint chronic psychotic patient

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

403

S-25-1 - The serotonin transporter: From molecular pharmacology to therapeutics

S.Z. Langer, D. Graham

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

404

S-25-3 - Neuronal transporters as candidate genes for affective disorders

K.P. Lesch, A. Heils, D. Bengel, A. Teufel, M. Seemann, S. Petri, S. Goßler, J. Gross, U. Balling, P. Riederer, G. Stöber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

405

S-25-5 - Clinical onset of antidepressant action: Implications for new drug development

W.Z. Potter, H.K. Manji

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

406

S-26-1 - The continuum of affective disorders in women — Diagnostic and therapeutic implications

Uriel Halbreich

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

407

S-26-2 - CNS roles of CRF and urocortin, their receptors and binding protein

W. Vale, J. Vaughan, C. Donaldson, M. Perrin, S. Sutton, J. Bittencourt, J. Rivier, P. Sawchenko

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

408

S-26-3 - Gender differences in the response to pharmacotherapy among early onset dysthymics

K.A. Yonkers, A.J. Rush, S. Kornstein, U. Halbreich, T. Pearlstein, A. Stone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

409

S-26-4 - Mood effects of hormonal interventions — Comparisons to conventional antidepressants

E.W. Freeman, K. Rickels, S.J. Sondheimer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 295 KB

english, 1996

410

S-26-5 - Psychopharmacology of pregnant and postpartum women

Z.N. Stowe, C.B. Nemeroff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

411

S-26-6 - The psychobiology of female specific mood disorders — Discussion

M. Steiner, E. Dunn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

412

S-27-1 - Platelet immunoreactivity and radiolig and binding to imidazoline receptors in depression

A. Halaris, J. Piletz, T. Ivanov, H. Zhu, S. Madakasira, Y.Z. Feng, N. Goldman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

413

S-27-2 - Imidazoline receptors: CNS pharmacology and clinical relevance

D.J. Nutt, A. Hudson, S. Husbands, H.C. Jackson, L. Lione, M.D. Lalies, J. Lewis, G. Reynolds

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

414

S-27-3 - I1 and I2 imidazoline receptors in the human striatum: Comparison to other species

G. Vauguelin, A. Flamez, E. Czerwiec, P. Vanderheyden, J.P. DeBacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

415

S-27-4 - Agmatine and other endogenous ligands at imidazoline receptors

D.J. Reis, S. Regunathan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

416

S-27-5 - Distribution and regulation of imidazoline receptors in the brain

J. Piletz, T. Ivanov, H. Zhu, H. Blackwell, A. Halaris

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

417

S-28-1 - Youth suicide in Victoria: A retrospective study

G.D. Burrows, WG. Tiller, J. Krupinski

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

418

S-28-2 - Latrogenesis and medication as potential factors in suicide and depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

419

S-28-3 - Postmortem brain and platelet receptor changes in suicide/depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

420

S-28-4 - G proteins in the postmortem brain of suicide victims

G.N. Pandey, Y. Dwivedi, S.C. Pandey, S. Goel, R. Conley, R. Roberts

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

421

S-28-5 - Low serum cholesterol, suicide and serotonin

W. Pitchot, B. Hild, M. Ansseau

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

422

S-29-1 - Pharmacological treatment of OCD: Are the specific serotonin reuptake inhibitors superior to clomipramine?

M. Flament, J.C. Bisserbe, P. Boyer, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

423

S-29-2 - Role of the terminal 5-HT autoreceptor in the orbitofrontal cortex in the mechanism of action of 5-HT reuptake inhibitors in obsessive compulsive disorder

P. Blier, M. EI Mansari, V. Ducharme, C. Bouchard

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

424

S-29-3 - New insights to the serotonin hypothesis of OCD

J. Zohar, Y. Sasson, R. Cohen, S. Kindler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

425

S-29-4 - Specific brain systems in obsessive-compulsive disorder treatment

L. Baxter, A. Brody, S. Saxena, J. Schwartz, R. Ackermann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

426

S-29-5 - New developments in impulsivity and compulsivity

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

427

S-30-1 - Dopamine receptor transcript expression in schizophrenia

J.H. Meador-Woodruff, S.P. Damask, V. Haroutunian, M. Davidson, P. Powchik, K.L. Davis, S.J. Watson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

428

S-30-2 - Glutamatergic abnormalities in the temporal lobe in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

429

S-30-3 - Temporal lobe cytoarchitectural pathology in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

430

S-30-4 - Altered gene expression for receptors and transmitters in prefrontal cortex of schizophrenics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

431

S-30-5 - The neuropathology of schizophrenia: Autoradiographic and in situ hybridization studies

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 277 KB

english, 1996

432

S-31-1 - Metabolism, kinetics and interactions in treating refractory depression

E.M. Sellers, M.K. Romach

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

433

S-31-2 - Treatment-resistant depression: Resistant and complicated depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

434

S-31-3 - Refractory depression: First line treatment

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

435

S-31-4 - Treatment refractory depression: Long term issues

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

436

S-31-5 - Implications of comorbidity for the treatment of depression

G.D. Burrows, T.R. Norman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

437

S-32-1 - Immediate early gene expression and the mechanisms of action of atypical antipsychotics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

438

S-32-2 - Multiple serotonin/dopamine receptor interactions contribute to atypical antipsychotic drug action

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

439

S-32-3 - Brain biochemistry in the normal and hypoglutamatergic state — What distinguishes atypical from typical antipsychotics? A multivariate approach

Nicholas Waters, Susanna Holm, A. Carlsson, Lars O. Hansson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

440

S-32-4 - Stabilization of brain DA systems in psychosis by concomitant 5-HT2 and α2-receptor blockade

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

441

S-33-1 - Actions of lithium on brain adenylyl cyclase: Role of magnesium

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

442

S-33-2 - Marcks: A key to the long-term therapeutic action of mood stabilizers in the brain?

R.H. Lenox, G.G. Watson, R.K. McNamara

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

443

S-33-3 - Regulation of transmembrane signalling systems by mood stabilizing agents: Therapeutic implications

Husseini K. Manji

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

444

S-33-4 - The inositol depletion hypothesis: Promise and problems

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

445

S-33-5 - Lithium effects on protein phosphorylation in bipolar and healthy subjects

R. Zanardi, G. Racagni, E. Smeraldi, J. Perez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

446

S-34-1 - NGF, how it all began and how modern technologies confirm and expand the original hypothesis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

447

S-34-2 - Modulation of activity-dependent neuronal plasticity: A new facet of neurotrophin action

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

448

S-34-3 - Neurotrophic factors: Biology & clinical potential

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

449

S-34-4 - Opposing effects of stress andantidepressants of neurotrophic factors

R.M. Post, M. Smith, S.R.B. Weiss, S. Beaulieu, D.-M. Chuang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

450

S-34-5 - A role for neurotrophins in the action of chronic antidepressant treatments

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

451

S-35-1 - Gender differences in health and mental health: Practical implications

Carol C. Nadelson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

452

S-35-2 - Estrogen in postmenopausal women with and without depression: EEG, endocrinological and psychometric studies

B. Saletu, U. Halbreich

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

453

S-35-3 - Gonadal hormones, GABA and benzodiazepine receptors

Abraham Weizman, Moshe Gavish

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

454

S-35-4 - Estrogen and thyroid hormones as adjuncts for antidepressant treatment of post-menopausal women

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 272 KB

english, 1996

455

S-35-5 - Pharmacotherapy of depression in women: Ethical, conceptual and practical considerations

Uriel Halbreich

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

456

S-36-1 - Adenosine receptors as a target for carbamazepine's action in the brain

D. Van Calker, K. Biber, J. Walden, M. Berger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

457

S-36-2 - Calciumantagonism as a common mode of action of some antiepileptic drugs in the treatment of epilepsies and affective disorders

J. Walden, J. von Wegerer, B. Heßlinger, M. Berger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

458

S-36-3 - New concepts in mood stabilization: Evidence for the effectiveness of valproate and lamotrigine

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

459

S-36-4 - Lamotrigine in treatment refractory manic depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 276 KB

english, 1996

460

S-36-5 - Oxcarbazepine, carbamazepine and valproate in the treatment of affective and disintegrative psychiatric disorders

H.M. Emrich, M. Leweke, U. Schneider

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

461

S-37-1 - Schizophrenia spectrum disorders: Electrophysiological and structural MRI features

R.W. McCarley, M.E. Shenton, B.F. O’Donnell, C.C. Dickey, D. Holinger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

462

S-37-2 - Childhood predictors of schizotypal features in non-psychotic adults

B. Cornblatt, M. Obuchowski, L. Erlenmeyer-Kimling

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

463

S-37-3 - Neurobiologyy of the schizophrenia spectrum

L.J. Siever, M. Buchsbaum, B. Cornblatt, P. Harvey, A. Bergman, B. Siegel, E. Hazlett, A. Callahan, A.S. New, J. Downhill

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

464

S-37-4 - A multidimensional approach to schizotypal disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

465

S-37-5 - Hippocampal volume reduction and cognitive deficits: Course from high risk to chronic schizophrenia

D. Velahoulis, W. Brewer, P. McGorry, G. Paton, A. Yung, S. Francey, C. Pantelis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

466

P-8-1 - Hypnotic use in a psychiatric department

S.H. Onen, I. Jalenques, A.J. Coudert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

467

P-8-2 - Long-term use of benzodiazepine hypnotics

T. Sugiyama, H. Takeuchi, K. Kobayashi, S. Isawa, C. Matsumoto, J. Ishigooka, M. Murasaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

468

P-8-3 - Sleep studies in insomnia based on generalized anxiety disorder with diphenhydramine/lorazepam (SomniumR)

G. Zyhlarz, B. Saletu, N. Brandstätter, R. Frey, P. Anderer, G. Gruber, G. Klösch, M. Mandl, E. Stanger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

469

P-8-4 - The effect of trazodone on sleep in healthy young adults

K. Kaneta, H. Hayasaka, M. Kawasaki, M. Ikemoto, S. Murakami, S. Hatta, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

470

P-8-5 - Effects of zopiclone, zolpidem and flunitrazepam on nocturnal psychomotor and cognitive functions in normal young subjects

A. Patat, F. Le Coz, C. Thebault, H. Allain, J.M. Gandon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

471

P-8-6 - Effects of zolpidem, triazolam and zopiclone on REM sleep and hippocampal theta activity in rats

M. Yoshimoto, H. Higuchi, M. Kamata, K. Yoshida, H. Takahashi, K. Ito, T. Shimizu, Y. Hishikawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

472

P-8-7 - Sleep endocrine effects of neuropeptide Y in men reveal a GABAA-agonistic action

A. Steiger, I.A. Antonijevic, S. Bohlhalter, H. Murck, R-M. Friboes, T. Schier, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

473

P-8-8 - Clinical and chronobiological effects of sleep deprivation on depressed patients

Naoto Yamada, Ken Ohi, Satoru Nakajima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

474

P-8-9 - Linkage study of narcolepsy in 7 Japanese families

A. Himei, H. Yoneda, Y. Inayama, J. Sakai, T. Sakai, T. Miki, Y. Honda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

475

P-8-10 - Acute nocturnal doses of short-acting benzodiazepines suppress melatonin secretion in humans

O. McNulty, T.R. Norman, P.J. Nathan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

476

P-8-11 - The relationship between serotonin and melatonin in the rat pineal gland

P.J. Nathan, T.R. Norman, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

477

P-8-12 - Changes in circadian rhythm of activity in depression model depend on dark/light phase of test start

J.M. Gaztelu, J.M. Montes, C. Barrenechea, M. Romero, J. Saiz-Ruiz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

478

P-8-13 - Effects of vitamin B12 on the lithium carbonate-induced prolongation of free-running period in rat circadian rhythms

S. Tsujimaru, Y. Ida, H. Fukuyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

479

P-8-14 - Circadian variation in the ambulatory and drinking activities after repeated administration of cocaine in rats

T. Asami, M. Shinoda, H. Kuribara, I. Ida, M. Mikuni, Y. Machiyama, I. Yukio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

480

P-8-15 - The role of dopamine system in the striatum on the light pulse induced PRCS

H. Fukuyama, S. Tsujimaru, Y. Ida

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

481

P-9-1 - Differing properties of dopamine agonists and partial agonists at the cloned human D21 and D4.4 receptors

R.A. Lahti, A. Mutin, E. Cochrane, D. Dijkstra, H. Wikström, A.C. Lahti, C.A. Tamminga

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

482

P-9-2 - Fos-like immunoreactivity in the rat brain induced by clozapine, risperidone, haloperidol, and haloperidol combined with antidepressant

Kwang-Soo Kim, Won-Myong Bahk, Yang-Whan Jeon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

483

P-9-3 - Similar effects of chronic clozapine and ‘Seroquel’ (ICI 204,636) administration on 1FosB expression in the forebrain

F. Ansari, Y. Nakabeppu, G.S. Robertson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

484

P-9-4 - Effect of YM-43611 and neuroleptics on c-fos expression in the rat forebrain

M. Narita, K. Kurokawa, K. Koshiya, J. Ohmori, K. Satoh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

485

P-9-5 - Receptor mechanisms mediating clozapine-induced c-fos expression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

486

P-9-6 - Differential roles of D2, D3 and D4 receptors in dopamine-related behaviors as assessed with a novel D3/D4 antagonist YM-43611

K. Koshiya, K. Nakatoh, H. Hattori, S. Usuda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 294 KB

english, 1996

487

P-9-7 - Dopamine D2 receptor change after repeated treatment with SM-9018, a novel neuroleptic

Y. Ohno, T. Ishibashi, K. Ikeda, K. Ishida, M. Nakamura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

488

P-9-8 - Is clozapine a dopaminergic drug?

S.W. Tang, D.M. Helmeste, H. Fang, M. Li, C. Widmark, C. Reist

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

489

P-9-9 - Comparison of the pharmacological profiles of zotepine and norzotepine

D.J. Heal, P.L. Needham

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

490

P-9-10 - BTS 73 947, a novel D1/D5 antagonist with predicted atypical antipsychotic activity

P.L. Needham, D.J. Heal, B.J. Sargent, W.R. Buckett

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

491

P-9-11 - Behavioral studies of OPC-14597, a novel antipsychotic drug

T. Kikuchi, Y. Uwahodo, K. Tottori, M. Nakai, T. Hirose, Y. Oshiro, S. Morita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

492

P-9-12 - Pharmacological profile of PR-000608, a novel dopamine uptake inhibitor

M. Inazu, M. Harada, N. Kubota, T. Masuda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

493

P-9-13 - The effects of clozapine and remoxipride on Latent Inhibition in rats

K.M. Trimble, W.R. Bell, D.J. King

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

494

P-9-14 - ‘Seroquel’ (ICI 204,636) and clozapine are effective in an animal model of the negative symptoms of schizophrenia

B. Ellenbroek, L. Lubbers, A. Cools

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

495

P-9-15 - Clozapine-like behavioral effects of ‘Seroquel‘ (LCI 204,636) in squirrel monkeys

G. Carey, J. Bergman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

496

P-9-16 - Pharmacology of ‘Seroquel’ (ICI 204,636): An atypical dibenzothiazepine antipsychotic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

497

P-9-17 - Response of animal model for tardive dyskinesia to central drugs

H. Takeuchi, Y. Kato, K. Yago, S. Watanabe, J. Ishigooka, M. Murasaki, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

498

P-9-18 - Seroquel restores prepulse inhibition of startle in phencyclidine-treated rats

N. Swerdlow, V. Bakshi, M. Geyer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

499

P-9-19 - Phencyclidine-induced schizophrenia negative symptom-like behavior in mice: Comparative study of risperidone andhaloperidol

Y. Noda, K. Yamada, T. Nabeshima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

500

P-9-20 - Effects of developmental phencyclidine exposure on auditory startle andlocomotor activity

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

501

P-9-21 - Effect of dantrolene on caffeine-induced dopamine release in rat striatum

T. Oyamada, T. Hayashi, A. Kagaya, N. Yokota, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

502

P-9-22 - Lipoxygenase pathway modulation of dopamine release

B. Davidson, A. Giangregorio, L. Lambert, D. Van Blerk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

503

P-9-23 - Effect of glutamate uptake inhibitor L-trans-PDC on amino acids in ratstriatum: Microdialysis study

J. Semba, M. Sakai, S. Kito

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

504

P-9-24 - Dopaminergic modulation of GABA release: In vivo microdialysis in freely moving rats

J. Javaid, I. Shim, D. Wirtshafter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

505

P-9-25 - Changes of monoamine synapses and behavior in rats induced by fetal injection of methylazoxymethanol

Y. Kodama, K. Kimura, M. Watanabe, K. Takishima, G. Mamiya, N. Ichinowatari

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

506

P-9-26 - The peculiarities of the meperedine action in early ontogenesis

H. Zlenko, H. Demechenko

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

507

P-9-27 - Inhibitory role of brain histaminergic neuron system on behavioral sensitization

C. Ito, K. Onodera, T. Watanabe, M. Sato

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

508

P-9-28 - Gonadal hormones and the presynaptic transporters for dopamine and serotonin in rat brain

G. Artali, I. Gil-Ad, R. Weizman, M. Rehavi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

509

P-9-29 - Activation of noradrenergic neurons in the rat locus coeruleus and noradrenaline release in the amygdala

M. Tanaka, H. Ishii, T. Nishikawa, M. Yoshida, H. Yokoo, T. Tanaka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 338 KB

english, 1996

510

P-9-30 - Anti-α2-GP and anti-GFAP antibodies as the vectors for targeted delivery of haloperidol into the glial cells

V. Chekhonin, A. Kabanov, I. Rjabukhin, O. Antonova, I. Belaeva, N. Khrustaleva, A. Anin, Yu. Alexandrovsky, T. Dmitrieva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 198 KB

english, 1996

511

P-10-1 - Platelet paroxetine binding in post-traumatic stress disorder

K. Maguire, T. Norman, M. Hopwood, P. Morris

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 198 KB

english, 1996

512

P-10-2 - Experimental study: Stress and memory

M. Le Poncin, I. Lamproglou

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 198 KB

english, 1996

513

P-10-3 - Interaction of glucocorticoid receptor with heat shock protein 90 after chronic stress

Y. Sasuga, M. Asakura, M. Miyamoto, N. Bodaiji, J. Imafuku, T. Matsushita, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 198 KB

english, 1996

514

P-10-4 - Effect of dilithium N-acetyl-L-aspartate on stress-induced dopamine release in hypothalamus

V. Petrov, I. Grigoryev, D. Zaretsky, V. Sergeyev

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

515

P-10-5 - Stress-induced phase-shifts inthe locomotor activity rhythm and increases in noradrenaline turnover inthe locus coeruleus region

S. Tsujimaru, Y. Ida, H. Egami

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

516

P-10-6 - The effect of prenatal stress on the development of the rat aminergic receptors and behavior

T. Asou, S. Yoshimoto, T. Tsujimura, Y. Tomimatsu, Y. Kakumoto, Y. Okazaki, Y. Nakane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

517

P-10-7 - Effects of acute and chronic administration of CCKB antagonist on conditioned fear stress

T. Izumi, T. Inoue, K. Tsuchiya, S. Hashimoto, T. Ohmori, T. Koyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

518

P-10-8 - Pharmacological regulation of anxiety in dependence on stress reaction phenotype

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

519

P-10-9 - Comorbidity and treatment features in social phobia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

520

P-10-10 - Sertraline in obsessive-compulsive spectrum disorders — A case study series

J.C. Bisserbe, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

521

P-10-11 - Effect size, placebo response and tolerability in clinical studies in obsessive-compulsive disorder

J.C. Bisserbe, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

522

P-10-12 - Generalized anxiety (GA) and panic attacks (PA): The pathogenic targets for psychopharmacology

A. Avedisova, B. Kogan, S. Paniushkina, N. Darovsky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

523

P-10-13 - Two-year follow-up after treatment of panic disorder with agoraphobia

A.J.L.M. van Balkom, E. de Beurs, R. van Dyck, A. Lange

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

524

P-10-14 - Double-blind comparison of sertraline and placebo in patients with panic disorder

B. Baumel, R. Bielski, J. Carman, W. Goodman, M. Hegel, C. Houck, R. Linden, B. Nakra, K. Ota, R. Rohl, R. Wolkow

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

525

P-10-15 - Can panic disorder patients treated with more than 4 mg/day of alprazolam reduce their dose?

M. Corrigan, J. Jonas, T. Kitt, S. Goldstein, A. Swiontek, S. Stahl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

526

P-10-16 - Efficacy and safety of paroxetine in panic disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

527

P-10-17 - Double-blind flexible dose study of sertraline and placebo in patients with panic disorder

R. Wolkow, J. Apter, A. Clayton, W. Coryell, L. Cunningham, W. McEntee, D. O’Hair, M. Pollack, J. Rausch, R. Stewart, R. Weisler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

528

P-10-18 - CCK-4 in cerebrospinal fluid: A pilot study in healthy male volunteers

T. Gunnarsson, T. Eklundh, M. Eriksson, C. Nordin, S. Sjöberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

529

P-10-19 - Effect of a major depressive episode history on the CCK-4 response in women

J.-M. Le Mélledo, J. Bradwejn, D. Koszycki, F. Bellavance, D.G. Bichet

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

530

P-10-20 - The role of the seta adrenergic system in CCK-4 induced panic symptoms

J.-M. Le Mellédo, J. Bradwejn, D. Koszycki, I. Jerabek, F. Jolicoeur, A. Cadieux, J.-P. Boulenger, F. Bellavance, D.G. Bichet

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

531

P-10-21 - Mutation in the cholecystokinin B receptor in panic disorder

M. Miyamoto, K. Isogawa, J. Akiyoshi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

532

P-10-22 - CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder

J. Akiyoshi, T. Moriyama, K. Isogawa, M. Miyamoto, I. Sasaki, K. Kuga, H. Yamamoto, K. Yamada, I. Fujii

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

533

P-10-23 - Effect of provoking panic attack agents on extracellular level of 5-hydroxytryplamine in hippocampus of free moving rats

K. Isogawa, M. Miyamoto, J. Akiyoshi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

534

P-10-24 - Anxiolytic activity of GV 150013, a new potent and selective cholecystokinin-B (CCK-B) antagonist

D.G. Trist, M. Corsi, F.Th.M. van Amsterdam, E. Ratti, G. Gaviraghi, A. Reggiani

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

535

P-10-25 - An association study between panic disorder and serotonin 2C receptor DNA marker

Y. Inada, H. Yoneda, Y. Inayama, Y. Nonomura, K. Kuroda, H. Asaba, T. Sakai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

536

P-10-26 - 5-HT2C receptor antagonists and anxiety disorders

T.P. Blackburn, S. Lightowler, G.A. Kennett, M.D. Wood, D.N. Middlemiss

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

537

P-10-27 - Anxiolytic effects of Y-23684 in normal humans with high- and low-anxiety

Y. Mizuki, M. Suetsugi, M. Yamada

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

538

P-10-28 - Anticonvulsant and anxiolytic effects of LY300164, an orally effective AMPA antagonist

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

539

P-10-29 - Benzodiazepine-mediated overactivation of 5-HT2 behavioural responses in rodents

I. Leonsegui, L. Salvador-Carulla

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

540

P-10-30 - Benzodiazepine-serotonin receptor interactions: Studies in animal behavioural models

T.R. Norman, A. Beveridge, G. Sedman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

541

P-10-31 - Activity of 5HT-3 receptor active compounds in animal behavioural models of anxiety

G. Sedman, P.L. Becker, T.R. Norman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

542

P-10-32 - The effects of the CCK antagonist, proglumide, on latent inhibition in rats

D.J. Gracey, W.R. Bell, D.J. King

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

543

P-10-33 - AP521, a novel benzothieno-pyridine derivative, shows anxiolytic activity

Tadashi Nagatani

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

544

P-10-34 - Bimodal effects of GABAergic drug penicillin on anxiety

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

545

P-10-35 - Modulation of grooming behaviour by GABAergic drug penicillin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

546

P-10-36 - New day tranquilizer — Tarden

P.P. Denisenko, M.P. Pukhov, N.P. Denisenko, A.A. Tarasenko, A.Z. Abyshev

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

547

P-10-37 - Anxiolytic effects of ziprasidone compared with diazepam and placebo prior to dental surgery

K.D. Wilner, R.J. Anziano, A.C. Johnson, J.J. Miceli, J.R. Fricke, C.K. Titus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

548

P-10-38 - Anxiety-depressive disorders after subarachnoid hemorrhage (SAH): Association with fatiguability

J.E. Starmark, M. Rödholm, E. Svensson, C. von Essen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

549

P-11-1 - Gender differences in body temperature during lorazepam tolerance and withdrawal

E. Elliot, J. White

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

550

P-11-2 - Withdrawal of lorazepam long-term administered using six different plans

P. Lemoine, J. Touchon, M. Billardon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

551

P-11-3 - Mechanistic studies with addictive sedative-hypnotics and related drugs in the mouse

A. Shulman, G. Laycock, G. Han

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

552

P-11-4 - An animal model of benzodiazepine withdrawal: The effect of 5HT-IC receptor active compounds

G. Sedman, L. Dwyer, T.R. Norman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

553

P-11-5 - Relationship between diazepam withdrawal signs and GABA receptor function in rats

S. Toki, A. Nabeshima, T. Saito, S. Hatta, M. Watanabe, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 283 KB

english, 1996

554

P-11-6 - Cognitive performance and mood changes over 24 hours of smoking abstinence

A.C. Parrott, N. Garnham, K. Wesnes

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

555

P-11-7 - The effects of nicotine on the Color Word Test

M. Nishimoto, K. Miyasato, Y. Ohashi, K. Kosuge, K. Ohashi, K. Ohara, M. Nakashima, Y. Maruyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

556

P-11-8 - Central nervous system distribution of c-fos expression in a rat model of nicotine craving

E. Merlo Pich, M. Tessari, D. Talabot, S. Pagliusi, C. Chiamulera

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

557

P-11-9 - Neural mechanisms of dependence on and psychotoxicity of nicotine and stimulants

T. Yanagita, K. Ando, A. Shimada

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

558

P-11-10 - Carbamazepine-mianserin in opiate withdrawal study: A dou

G. Bertschy, C. Bryois, G. Bondolfi, A. Velardi, D. Baettig, P. Baumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

559

P-11-11 - Alternative pharmacotherapies in the treatment of opioid addiction

J.H. Broadbear, J.W. Lewis, J.H. Woods

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

560

P-11-12 - Methadone plasma levels in a methadone maintenance treatment

M. Torrens, C. Castillo, L. San, E. del Moral, R. de la Torre

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

561

P-11-13 - The mRNA expression of G protein subclasses in the methamphetamine-induced behavioral sensitization

Hiroto Iwasa, Shuichi Kikuchi, Kaori Suzuki, Shuji Hasegawa, Toshio Sato

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

562

P-11-14 - Dopaminergic modulation of hypothalamic self-stimulation of socially isolated rats with lesions of brain mesolimbic structures

Peter D. Shabanov, Gennady N. Panchenko, Andrei A. Lebedev

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

563

P-11-15 - Induction of immediate early genes following rewarding brain stimulation

G.E. Hunt, I.S. McGregor

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

564

P-11-16 - Flupenthixol and desipramine treatment of crack users: Double blind results

F.H. Gawin, M.E. Khalsa-Denison, P. Jatlow

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 293 KB

english, 1996

565

P-11-17 - Incidence of drug dependecy in employees with term sick leave in the minicipality of trollhättan

I. Fagemo, I. Carlsson, P. Persson, G. Björling

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

566

P-12-1 - Minimum effective doses of SSRIs

R. Magnus, S. Preskorn, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

567

P-12-2 - The SSRI withdrawal syndrome

S. Preskorn, R. Lane, R. Magnus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

568

P-12-3 - Effects of the SSRIS on cognitive function

T. Oxman, R. Lane, E. Richter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 294 KB

english, 1996

569

P-12-4 - Predictors of response to SSRIs in patients with major depression

J.C. Bisserbe, R. Lane, R. Wiseman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

570

P-12-5 - Clinical experience with paroxetine: A review

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

571

P-12-6 - A double-blind multicentre comparison of paroxetine and amitriptyline in australian general practice

E. Freed, T. George, R. Goldney, T. Lambert, J. Tiller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

572

P-12-7 - Antidepressant effects of paroxetine in korean patients with major depression

H.S. Lee, S.K. Min, C.H. Kim, D.H. Song, K. Namkoong, W.T. Jeon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

573

P-12-8 - A review of the psychomotor effects of paroxetine

C.J. Hawley, S.A. McPhee, V.R.H. Smith, A.G. Roberts

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

574

P-12-9 - Cross-over study of sertraline versus imipramine in chronic depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

575

P-12-10 - Sertraline versus imipramine in the acute and continuation treatment of dysthymia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

576

P-12-11 - Treatment of severe major depression: A double-blind study of sertraline and clomipramine

J. Lépine, R. Wiseman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

577

P-12-12 - The efficacy of sertraline in the treatment of major depression

D. Bugarski-Kirola, A. Damjanović, V.R Paunović, Dj. Živkovic, Z. Stanković

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

578

P-12-13 - Sertraline in continuation therapy

S. Montgomery, R. Lane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

579

P-12-14 - Sexual side effects during sertraline treatment of patients with major depression: A naturalistic study

A. Lista Varela

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

580

P-12-15 - A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment of major depression

P.R. Latimer, A.V. Ravindran, J.-P. Bernatchez, J.-P. Fournier, J.A. Gojer, K. Barratt, J. Buttars

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

581

P-12-16 - A double blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in out patient

D. Sechter, S. Troy, P. Rioux

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

582

P-12-20 - Clinical differences in response to mianserin and fluoxetine in depressive patients

F. Lavergne, I. Berlin, C. Payan, G. Besançon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 283 KB

english, 1996

583

P-12-18 - Serotonergic (fluoxetine) versus noradrenergic (maprotiline) antidepressants and suicidality

M. Jakovljević, D. Vujić, N Henigsberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

584

P-12-19 - Outcomes including withdrawal phenomena detected from a naturalistic comparison of fluoxetine and paroxetine used in the treatment of affective disorders in patients with learning disabilities

S. Bhaumik, H.J. Wildgust

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

585

P-12-17 - Psychotropic comedication and adverse event rates. Results from a fluoxetine drug surveillance study

R.W. Dittmann, M. Linden, M. Osterheider

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

586

P-12-21 - Preliminary results of a randomized double blind study of amisulpride Vs fluoxetine in 281 dysthymic patients

F. Biondi, G. Casadei

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

587

P-12-22 - Efficacy and tolerability of fluoxetine compared with maprotiline in major depressive episode: Results of central-east european study

M. Jakovljeviç, D. Vujiç, Y. Aleksandrovsky, W. Szerenberger, F. Faltus, N. Henigsberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

588

P-12-23 - Fluvoxamine alone in the treatment of delusional depression

R. Zanardi, J. Perez, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

589

P-12-24 - Effectiveness of fluvoxamine therapy in cardiological patients suffering from depression

J. Radics, P. Mézes, Gy Ostorharics

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

590

P-12-25 - Fluvoxamine and lithium in long-term treatment of unipolar subjects

R. Zanardi, L. Franchini, J. Perez, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

591

P-12-26 - Dexamethasone augmentation of sertraline response in resistant depression

T. Dinan, J. Cooney, E. Lavelle, C. Berti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

592

P-12-27 - Buspiron augmentation of SSRI therapy in treatment-refractory depression

T. Fahlén, H. Ågren, A. Edström, K. Rooth

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

593

P-12-28 - Safety & tolerability of combined treatment with moclobemide and SSRIs: A preliminary study

C.J. Hawley, S. Ratnam, S. Quick, D. Echlin, H. Pattinson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

594

P-12-29 - Use of combined SSRIS and moclobemide in treatment-resistant depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

595

P-12-30 - A protocol for the pharmacologic treatment of major depression

C.J. Hawley, H.A. Pattinson, S.J. Quick, S.A. McPhee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

596

P-12-31 - Compliance to psyopharmacological treatment: Suggestions for its improvement

J. Mantonakis, G.N. Christodoulou

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

597

P-12-32 - Temperament, character, and molecular genotypes as predictors of antidepressant response

H. Nicolini, K. Herrera, F. Páez, B. Camarena, R. Guajardo, J.R. De la Fuente

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

598

P-12-33 - Polypharmacy: What is its role in the long-term use of antidepressants?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

599

P-12-34 - Economic impact of improved work performance after treatment of chronic depression

J.M. Russell, S.N. Finkelstein, E.R. Berndt, P.E. Greenberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

600

P-12-35 - Utility-based measures of health-related quality of life in depression

K.J. Bennett, G.W. Torrance, M.H. Boyle, R. Guscott

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

601

P-12-36 - Dexamethasone suppression test in depression

Dj. Živkovic-Milovanović, D. Bugarski-Kirola, Z. Stanković, A. Damjanović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

602

P-12-37 - 5-HT2A receptor gene is intact in mood disorder

K. Ohara, H.Y. Zhang, T. Ishigaki, D.W. Xie, K. Tani, K. Miyasato, K. Ohara

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

603

P-12-38 - Anticipation and repetitive elements of the serotonin transporter gene in affective disorder

M. Hayashida, T. Tsujita, A. Imamura, Y. Okazaki, N. Niikawa, Y. Nakane, S. Matsumoto

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

604

P-12-39 - Platelet serotonin2 receptor binding in affective disorders

T. Tsujimura, T. Asou, M. Hayashida, A. Himeno, H. Minami, Y. Okazaki, Y. Nakane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

605

P-12-40 - Strong and long-lasting inhibition of 5-HT uptake of platelets in subjects treated by duloxetine, an antidepressant candidate

T. Kasahara, E. Nagata, A. Takahashi, J. Ishigooka, M. Murasaki, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

606

P-12-41 - Tryptophan depletion in recovered depressives and recovered bulimics

K.A. Smith, C.G. Fairburn, P.J. Cowen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

607

P-12-42 - Therapeutic advantage of combined amitriptyline/Lithium and fluvoxamine/lithium treatments

B. Miljković, M. Pokrajac, I. Timotijević

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

608

P-13-1 - Saccadic eye movements in gilles-de-la-tourette-syndrome

N. Müller, M. Riedel, J.B. Mennicken, Th. Eggert, A. Straube

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

609

P-13-2 - In vivo examination of the Pre- and postsynaptic dopamine neurons in huntington's disease

N. Ginovart, A. Lundin, L. Farde, C. Halldin, C.G. Swahn, S. Pauli, G. Sedvall

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

610

P-13-3 - The effects of cues on executive functions of parkinsonian patients

C.T. Tai, C.H. Juan, C.K. Liu, R.T. Lin, C.L. Lai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

611

P-13-4 - Tolcapone therapy improves cognitive functions in nondemented patients with advanced parkinson's disease

G. Meco, M. Gasparini, R. Di Fabio, N. Vanacore, V. Bonifati

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

612

P-13-5 - Acute administration of levodopa + carbidopa before and after four months of treatment with Tolcapone in advanced Parkinson's disease

G. Meco, P. Zuchegna, E. Fabrizio, N. Vanacore

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

613

P-13-6 - Risperidone in levodopa induced psychosis in advanced Parkinson's disease. An open label, long-term study

G. Meco, A. Alessandri, P. Giustini, V. Bonifati

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

614

P-13-7 - Parkinsonism, negative symptomatology and subjective patient's experience

G.F. Marchesi, G. Santone, P. Cotani, S. Giuliani, F. Delicati, F. Chelli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

615

P-13-8 - A fifteen year follow-up study of tardive dyskinesia and drug induced Parkinsonism

G. Gardos, D.E. Casey, A. Perenyi, J.D. Cole, E. Kocsis, J.A. Samson, W. Wycoff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

616

P-13-9 - Effects of OPC-14117 on dopaminergic neuronal degeneration induced by MPTP

Y. Uwahodo, K. Tottori, T. Kikuchi, M. Nakai, T. Miwa, T. Hirose, Y. Oshiro, S. Morita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

617

P-13-10 - Awareness of tardive dyskinesia and its relationship to tardive dysmentia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

618

P-13-11 - Cognitive impairment and tardive dyskinesia

C.L. Shriqui, L. Annable, C. Doucet

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

619

P-13-12 - Long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol

J. Street, R. Tamura, T. Sanger, G. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

620

P-13-13 - Ratio of neuroleptic to anticholinergic level and extrapyramidal symptoms induced by nemonapride

N. Yamaguchi, M. Kamirnura, Y. Morokawa, H. Fujimaki, H. Watanabe, Y. Nagatsu, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 272 KB

english, 1996

621

P-13-14 - Akathisia, iron and cortisol

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 130 KB

english, 1996

622

P-14-1 - Irritability rating scale: Validity and reliability

Ole J. Thienhaus, Jacqueline Collins

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 130 KB

english, 1996

623

P-14-2 - Continuous infusion of haloperidol and delerium in intensive care unit

A. Aït-ameur, J.M. Doise, A. Leuret-Barondeau, L. Piroth, H. Aube, B. Blettery, A. Gisselmann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 130 KB

english, 1996

624

P-14-3 - Bluenotes (on physicians noncompliance)

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 130 KB

english, 1996

625

P-14-4 - Analgetic properties of some prolin-containing oligopeptides, having antiulcer effect

G.N. Kopylova, Ch.V. Mamedov, G.E. Samonina

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 130 KB

english, 1996

626

P-14-5 - Ketamine: Neurophysiological study of subanesthetic doses in patients with chronic pain

K. Oga, M. Matsuura, M. Nagashima, T. Kojima, J. Kato, S. Ogawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 112 KB

english, 1996

627

P-14-6 - The influense of ketamine pharmacokinetics on the activity of neurotransmitter systems in humans under surgical stress

N.A. Davydova, R.A. Tigranian, T.F. Borovkova, M.M. Abackumov, B.G. Gillis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 112 KB

english, 1996

628

P-14-7 - Functional state of thesystem DOPHA-dophamini (DA)-noradrenalini (NA)-adremalini (A) under epilepsy

V.A. Karlov, M.A. Gleyzer, N.D. Sorokina

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 112 KB

english, 1996

629

P-14-8 - Psychiatric morbidity in candidates for normal volunteer trials

V. Gentil, C. Gorenstein, L. Andrade

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 112 KB

english, 1996

630

O-16-1 - Olanzapine use after clozapine induced granulocytopenia

J.R. Swartz, J. Ananth, M. Smith, K. Burgoyne, R. Gadasally

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

631

O-16-2 - Eight-week administration of antipsychotic drugs decreases the sensitivity of vasopressin secretion

T. Kishimoto, K. Kitera, N. Shimayoshi, Y. Noriyama, Y. Inoue, N. Higashiura, H. Matsumoto, K. Nakagawa, H. Ohsawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

632

O-16-3 - Duration of initially untreated psychosis, negative symptoms and cognitive impairment in schizophrenia

P.J. Scully, G. Coakley, H.A. Youssef, A. Kinsella, J.L. Waddington

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

633

O-16-4 - A case-control study of neuroleptic malignant syndrome

P. Sachdev, C. Mason, D. Hadzi-Pavlovic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

634

O-16-5 - Antibodies to human heat, shock protein in patients with schizophrenia and major depression

P. Sirota, A. Novogrotsky, D. Mazeh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

635

O-16-6 - Specific cognitive deficits in schizophrenia

M. Large, B. O’Sullivan, G. Smith, D. Kavanagh, N. Barrett, F. Karayanidis, P. Michie

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

636

O-16-7 - Positive association between dopamine D4 receptor polymorphism and schizophrenia

M. Nakamura, J. Suzuki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

637

O-16-8 - The effect of neuroleptic drugs on olfactory sensitivity in schizophrenia

Pinkhas Sirota, Israel Ben-David, Keren Luca-Haimovici, Joseph Zohar, Ruth Gross-Isseroff

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

638

O-16-9 - Haloperidol-induced NGF plasma levels changes in schizophrenic patients

L. Aloe, G. Bersani, A. Iannitelli, P. Maselli, A. Garavini, F. Angelucci, E. Alleva, P. Pancheri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

639

O-16-10 - Olfactory and neuropsychological deficits in high-risk & first episode psychosis

W. Brewer, S. Francey, A. Yung, D. Velakoulis, V. Anderson, P. McGorry, D. Copolov, B. Singh, C. Pantelis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

640

O-17-1 - Nightmares: Their relationships with mental disorders and sleep disorders

M.M. Ohayon, R.G. Priest, C. Guilleminault, M. Caulet

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

641

O-17-2 - Effects of ethyl loflazepate on nocturnal sleep and sleeps pindle in normal humans

M. Suetsugi, Y. Mizuki, M. Yamada

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

642

O-17-3 - Relationship between sleep disturbance and pain in patients with fibromyalgia and concomitant treatment with the 5-HT2-receptor antagonist ketanserine

U. Hemmeter, R. Kocher, M. Hatzinger, E. Seifritz, R. Bischof, C.J. Lauer, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

643

O-17-4 - Delta-hypohypnia: A new mechanism for chronic intractable insomnia?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

644

O-17-5 - Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone

J.M. Monti, H. Jantos, R. Silveira, M. Reyes-Parada, C. Scorza

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 297 KB

english, 1996

645

O-17-6 - Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder

J.C. Gillin, A.J. Rush, R. Armitage, H. Moldofsky

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

646

O-17-7 - Specificity of sleep EEG changes in psychiatric disorders: Data from a comparative study

F. Arriaga, E. Lara, J. Maltez, F. Cavaglia, A. Matos-Pires

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

647

O-17-8 - Lipid parameters in depressed and non-depressed patients with sleep apneas syndrom

P. Lemoine, A. Blassier, T. Hueber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

648

O-17-9 - Effects of additional bright light therapy on sleep-EEG in depressed patients

U. Hemmeter, M. Müller, M. Hatzinger, E. Seifritz, R. Bischof, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 295 KB

english, 1996

649

O-17-10 - The effect of paroxetine and nefazodone on sleep: A placebo controlled trial

A.L. Sharpley, D.J. Williamson, M.E.J. Attenburrow, G. Pearson, P. Sargent, P.J. Cowen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

650

O-18-1 - Atypical neuroleptic profile in rodents of L-701,324, an antagonist at the glycine/NMDA receptor

P.H. Hutson, M.D. Tricklebank, L.J. Bristow

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

651

O-18-2 - Clozapine in the latent inhibition (LI) model: Atypical or a typical neuroleptic?

I. Weiner, E. Shadach, J. Feldon

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

652

O-18-3 - Specific activation of limbic dopaminergic structures in rat brain by Ca2+ channel blockers

J. Vetulani, L. Antkiewicz-Michaluk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

653

O-18-4 - Dopamine antagonists increase muscle tone by blocking dopamine receptors in the substantia nigra of the rat

A.D. Crocker, K.M. Hemsley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 296 KB

english, 1996

654

O-18-5 - New atypical antipsychotics olanzapine and ICI 204,636 vs clozapine in ‘D1-like’ vs ‘D2-like’ functional models

A.M. Deveney, J.L. Waddington

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

655

O-18-6 - Glucocorticoid-dependent AP-2 activation of the phenylethanolamine N-methyltransferase gene

D.L. Wong, S.N. Ebert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

656

O-18-7 - Antisense “Knockout” of brain dopamine receptors

I. Creese, J. Tepper, B. Sun, A. Ouagazzal, M. Zhang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 160 KB

english, 1996

657

O-18-8 - Behavioural and biochemical effects of dopamine D3 antisense administration

A. Ekman, H. Nissbrandt, M. Heilig, E. Eriksson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

658

O-18-9 - CAG repeat polymorphism in schizophrenia

H.G. Hwu, H.C. Hsu, C.T. Chu, Y.L. Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

659

O-19-1 - Acute phase proteins in major depression

Michael Berk, Ahmed A. Wadee, Alex J. O’Neill-Kerr

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

660

O-19-2 - Plasma and platelet amino acids in major depressed patients treated with fluvoxamine

M.C. Mauri, A. Ferrara, L. Boscati, F. Zamberlan, M. Alecci, G. Invernizzi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

661

O-19-3 - Refractory depression a biochemical hypothesis

R.K. Gupta, T.R. Norman, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

662

O-19-4 - Buspiron augmentation of SSRI therapy in treatment-refractory depression

T. Fahlén, H. Ågren, A. Edström, K. Rooth

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

663

O-19-5 - Pramipexole in major depression — An open clinical trial

A. Szegedi, H. Wetzel, A. Hillert, E. Klieser, W. Gaebel, O. Benkert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

664

O-19-6 - A six month sertraline fluoxetine comparative study in depressed outpatients: Outcome and costs

J.C. Bisserbe, P. Boyer, E. Souêtre, J.M. Hotton, S. Troy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

665

O-19-7 - Comparison of efficacy and tolerability of fluoxetine in ambulatory and hospitalized patients with major depression

I. Timotijević, V.R. Paunović, Z. Pavlović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

666

O-19-8 - Comparison of effects of paroxetine and amitriptyline on driving and psychomotor performance in depression

G. Starmer, D. Mascord, SmithKline Beecham International

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

667

O-19-9 - SSRI, L-Tryptophan and serotonin syndrome. Experience with 75 patients

J. Ciprian-Ollivier, M. Cetkovich-Bakmas, J. Albin, G. Vázquez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

668

O-19-10 - Antidepressants and weight: A comparative study of four antidepressants and their effect on weight

A.F. Joubert, C.A. Gagiano, G. Joubert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

669

O-20-1 - Similarities in Cognitive impairment profiles between mild dementia of Alzheimer type and anticholinergic agents

Y. Morokawa, H. Watanabe, T. Ohta, N. Yamaguchi, A. Aoba

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

670

O-20-2 - Use of anticholinergic eye drops in differentiating Alzheimer's disease and depression

I. Schweitzer, V. Chang, J. Kabov, D. Ames, A. Vingrys, V. Tuckwell

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

671

O-20-3 - Scopolamine is a model of memory dysfunction, not of aging

W. Riedel, E. Hogervorst, F. Verhey, J. Jolles

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

672

O-20-4 - The M1 muscarinic agonist xanomeline improves both cognitive and behavioral deficits in Alzheimer's disease

N. Bodick, W. Offen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

673

O-20-5 - Pharmacological studies on bacopa monniera, an Ayurvedic nootropic agent

B.N. Dhawan, H.K. Singh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

674

O-20-6 - The effects of rilmenidine on memory, attention and planning in the elderly

A.G. Mander, E.L. Conway, W.J. Louis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

675

O-20-7 - The mechanism of amyloid β-Peptide (1–42) toxicity in PC12 cells

M. Fagarasan, S. Efthimiopoulos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 279 KB

english, 1996

676

O-20-8 - Prospective study of the effect of APOE genotype on cognitive performance in the very old

L. Altstiel, R. Mohs, D. Marin, L. Lebow, X-P Yang, M. Keddache, D. Greenberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

677

O-20-9 - Cognitive process produces inactivated serotonin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

678

O-20-10 - Hypoxia and hyperventilation as models for cognitive deficiencies

E. Hogervorst, W. Riedel, M. Van Boxtel, P. Visser, P. Hameleers, S. Sey, J. Jolles

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

679

O-21-1 - Localization and quantification of serotonin-1a, MR and GR mRNA in human hippocampus

J.F. López, K.Y. Little, D.P. MacLaughlin, S.J. Watson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

680

O-21-2 - Long-term changes induced by anti-depressant drugs in the presynaptic release machinery

M. Popoli, C. Vocaturo, J. Perez, L. Buffa, G. Racagni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

681

O-21-3 - Modulation of 5-HT activity by a new endogenous peptide, directy interacting at 5-HT1B/1D receptors

G. Fillion, J.C. Rousselle, O. Massot, M.P. Fillion, R. Hen, N. Prudhomme

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

682

O-21-4 - Effects of psychoactive agents on second messenger formation in rat brain as determined by in vivo microdialysis

Michael E. Newman, Eitan Gur, Bernard Lerer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

683

O-21-5 - Regulation of 5HT2A receptors and protein kinase C by dexamethasone and corticosterone in the rat brain

Y. Dwivedi, Y. Dwivedi, S.C. Pandey, X. Ren

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

684

O-21-6 - Opioid receptor binding properties of [3H]Buprenorphine in rat brain

A. Borsodi, F. Ötvös, G. Tóth, S. Hosztafi, C. Simon, S. Benyhe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

685

O-21-7 - Phosphorylation by Ca2+/Calmodulin-dependent protein kinase II. Effect on Ca2+/Phospholipid binding

M. Popoli, L. Buffa, A. Venegoni, G. Racagni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

686

O-21-8 - The study of signal transduction during the action of some memory modulators

O.G. Kulikova, B.A. Reikhardt, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

687

O-21-9 - Protein kinase C regulates platelet serotonin transporter

D. Marazziti, M.R. Mazzoni, L. Palego, A. Sbrana, M. Fancelli, A. Rossi, A. Lucacchini

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

688

O-22-1 - Co-administration of paroxetine and haloperidol in chronic schizophrenia

M.S. Lee, S.H. Kim, C.S. Han

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

689

O-22-2 - SSRI Augmention of antipsychotics in the treatment of negative symptoms

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

690

O-22-3 - Olanzapine X haloperidol: The results of a double blind study on acute psychotic patients

K. Burgoyne, J. Ananth, M. Smith, J.R. Swartz, R. Gadasally, P. Arns

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

691

O-22-4 - ‘Seroquel’ (ICI 204,636): An atypical antipsychotic: Results from a multiple fixed dose, placebo-controlled study

L.A. Arvanitis, B.G. Miller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

692

O-22-5 - Tolerability of low dose neuroleptics: A pseudoprospective, blind investigation of flupenthixol

J. Fritze, I. Spreda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

693

O-22-6 - Retrospective study on longtime treatment iwth clozapine

R. Battegay, D. Das, G. Brogiolo, H.R. Wacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

694

O-22-7 - Zotepine in acute exacerbation of schizophrenia: A comparison versus chlorpromazine and placebo

S.J. Cooper, J. Raniwalla, C. Welch

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

695

O-22-8 - Controlled comparison of terguride and perphenazine in acute schizophrenia

J. Švestka, E. Češková, V. Kamenická, A. Burešová

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

696

O-22-9 - A clinical trial with risperidon on chronic schizophrenics

T.K. Bastaman, R. Budiman, A. Kumawardhani, Amir N. Irmansyah, R. Salan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

697

O-22-10 - Clinical trial on antipsychotic effects of the sigma lignad panamesine in schizophrenia

A. Steiger, R-M. Frieboes, H. Murck, K. Wiedemann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

698

O-22-11 - Dose response of D-Cycloserine, a partial NMDA-Glycine site agonist, in schizophrenia

D.C. D’Souza, D. Abi-Saab, D. Damon, J. White, R. Gil, J.H. Krystal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

699

S-38-1 - Treatment of social phobia

S.A. Montgomery, D.B. Montgomery, A. Kotak

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

700

S-38-2 - Social phobia: A debilitating disease that needs treatment

J.J. López-Ibor Jr., J.L. Ayuso Gutiérrez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

701

S-38-3 - Comorbidities in social phobia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

702

S-38-4 - Social phobia: What is it and who has it?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

703

S5-38-51 - 51 Moclobemide for anxiety disorders: A focus onmoclobemide in panic disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

704

S-39-1 - Corticosteroid-serotonin interaction in rat brain:Pathophysiological implications

E.R. de Kloet, O.C. Meije, M. Joëls, M. Oitzl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

705

S-39-2 - Stress; Corticosteroids hypersecretion; Amono-aminergic dysregulation. A depressogeniccascade

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

706

S-39-3 - Long-term impact of stressors and affective episodes on vulnerability to recurrence and cycling

R.M. Post, S.R.B. Weiss

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

707

S-39-4 - Disturbed hypothalamic-pituitary axis indepression

C. Nicholson, B. Peeters, C. Broekkamp

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

708

S-39-5 - Antidepressants and the HPA system

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

709

S-40-1 - Interactions between cyclothiazide and 2,3-benzodiazepines in vivo and in vitro

D. Lodge, D. Bleakman, A. Palmer, M. Woolley, A. Bond

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

710

S-40-2 - Allosteric modulation of AMPA receptor function

K. Partin, M. Fleck, D. Bowie, R. Bähring, M.L. Mayer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

711

S-40-3 - Thiazide derivatives block rapid AMPA receptordesensitization

Steven M. Rothman, Kelvin A. Yamada, Douglas F. Covey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

712

S-40-4 - Positive allosteric modulation of AMPA or GABAAreceptors antagonizes alprazolam induced learning impairment in monkeys

E. Costa, J. Auta, J.M. Thompson, A. Guidotti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

713

S-41-1 - Dopamine and reward mechanisms: Implicationsfor mood disorders

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

714

S-41-2 - Functions of the Central Dopamine Systems inCognition; Relevance to human depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

715

Retardation and the classification of major depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

716

S-41-4 - Investigation of dopamine receptor function inmajor depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

717

S-41-5 - Sleep deprivation, mood enhancement anddopamine receptor binding in vivo in depression

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

718

S-42-1 - Placebo response in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 141 KB

english, 1996

719

S-42-2 - Pattern analysis predicts relapse on fluoxetine and placebo during continuation

F.M. Quitkin, J.W. Stewar, P.J. McGrath, C. Beasley

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 275 KB

english, 1996

720

S-42-3 - Are drug-placebo differences in the treatment ofanxiety disorders shrinking over the years?

K. Rickels, E. Schweizer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

721

Growing placebo effect — The problem in recent therapeutic trials?

E.H. Uhlenhuth, W. Matuzas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

722

S-42-5 - Placebo effects in alcohol dependence

P.J. Geerlings, S. Chabac, A. Potgieter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

723

S-42-6 - Placebo-induced side effects in clinical trials with schizophrenic patients

W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

724

S-43-1 - Noradrenergic hyperactivity and spontaneous recurrence of methamphetamine psychosis

K. Yui, K. Goto, S. Ikemoto, T. Ishiguro

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

725

S-43-2 - Schizophrenia: Correlation with phencyclidine-induced psychosis and neurochemical mechanisms

S.F. Ali, H.S. Bracha

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

726

S-43-3 - Behavioral neurotransmitter responses to a “binge” pattern of amphetamine administration

R. Kuczenski, D.S. Segal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

727

S-43-4 - Evidence for sensitization in the early stage of schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

728

S-43-5 - Predicting duration of clinical stability following haloperidol withdrawal in schizophrenia

D.P. van Kammen, M.E. Kelley, J.A. Gurklis, M.W. Gilbertson, J.K. Yao, R. Condray, J.L. Peters

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

729

S-43-6 - Cocaine psychosis and addiction: A role for sensitization and search for substrates

E. Bartler, A. Hallin, B. Chapman, B. Angrist, R. Hitzeman, G.J. Wang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

730

S-44-1 - Receptor-coupled G protein function in mood disorders

Sofia Avissar, Gabriel Schreiber

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

731

S-44-2 - Intracellular calcium signaling-related system in affective disorders and their treatment

A. Kagaya, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

732

S-44-3 - Protein phosphorylation as intracellular target of antidepressants

G. Racagni, S. Mori, A. Dorigo, N. Brunello, M. Popoli, J. Perez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

733

S-44-4 - Protein phosphorylation involved in the mechanism of antidepressant drugs

M. Asakura, S. Miyamoto, Y. Sasuga

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

734

S-44-5 - Antidepressant drug-induced modulation of serotonergic gene expression

K.P. Lesch, A. Heils, H.J. Degen, P. Riederer, D. Bengel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

735

S-44-6 - Intracellular signaling system as a new direction in affective disorders research

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

736

S-45-1 - Chemical neuroanatomy of the human brain, post mortem strategies

Göran C. Sedvall

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

737

S-45-2 - Distribution of dopamine receptor subtypes in the post-mortem human brain

H. Hall, Y.L. Hurd, M. Suzuki, L. Farde, C. Halldin, G. Sedvall

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 143 KB

english, 1996

738

S-45-3 - Mapping and characterizing 5HT receptors in the human brain

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 277 KB

english, 1996

739

S-45-4 - Excitatory amino acids in the human brain

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

740

S-45-5 - Imaging the gene expression of opioid peptides in the post-mortem human brain

Y.L. Hurd, S. Pauli, G. Sedvall

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

741

1153 - holinergic and peptidergic markers in the Alzheimer's brain: Possible relevance to therapy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

742

S-46-4 - Interactions between NMDA/Nitric oxide systems and σ receptors in learning and memory in mice

T. Nabeshima, Y. Noda, T. Mamiya, K. Yamada, T. Maurice

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

743

S-46-5 - Role of sigma receptors in motor control

Michael J. Walker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

744

S-47-1 - Chronic benzodiazepine use in the general population

P. Boyer, J.P. Lépine, W. Rein, J.C. Bisserbe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

745

S-47-2 - Benzodiazepines use in the medically III population: Impact of psychopathology and somatic morbidity

A. Pelissolo, J.C. Bisserbe, E. Weiller, P. Boyer, Y. Lecrubier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

746

S-47-3 - Receptor mechanisms of benzodiazepine dependence

J. Potokar, N. Coupland, J. Bailey, D.J. Nutt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

747

S-47-4 - The pharmacological management of benzodiazepine withdrawal

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

748

S-47-5 - Benzodiazepines and antidepressants in the treatment of generalized anxiety

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

749

S-47-6 - Serotonergic agents in the treatment of anxiety: Is the 5HT1A receptor a good target?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

750

S-48-1 - The role of environmental and cognitive function in the development of behavioral sensitization

T. Ohmori, T. Koyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

751

S-48-2 - Sensitization to psychostimulants depends upon glutamate transmission in the nucleus accumbens

P.W. Kalivas, K. Bell, R.C. Pierce, T. Duffy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

752

S-48-3 - On the functional significance of behavioral sensitization

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

753

S-48-4 - The integrity of serotonin function and sensitization to cocaine

K.A. Cunningham, R. De La Garza, R.T. Windh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

754

S-48-5 - Stimulant-induced behavioral sensitization and gene expression in developing rats

Y. Kajii, S. Toda, T. Hashimoto, A. Kashiwa, A. Umino, T. Nishikawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

755

S-49-1 - Genetic mechanisms in response to haloperidol and risperidone treatments

F. Macciardi, R. Cavallaro, S. Cohen, M. Masellis, M. Verga, J.L. Kennedy, A. Serretti, S. Pedrini, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

756

S-49-2 - Genetic studies of dopamine and serotonin system genes in clinical response to clozapine

J.L. Kennedy, F. Badri, M. Masellis, A. Petronis, C. Marino, F. Macciardi, H.H.M. Van Tol, P. Cola, H.Y. Meltzer, J. Lieberman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

757

S-49-3 - Molecular genetic studies of variation in dopamine and serotonin receptor genes

M.M. Nöthen, M. Rietschel, S. Cichon, J. Erdmann, D. Shimron-Abarbanell, G. Stöber, P. Propping

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

758

S-49-4 - Genetic markers and lithium prophylactic treatment of bipolar affective disorder

D. Souery, O. Lipp, P.O. Nylander, M. Verga, B. Mahieu, R. Adolfsson, F. Macciardi, C. Vanbroeckhoven, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

759

S-49-5 - Pharmacogenetic factors in schizophrenia: Treatment response and adverse effects

R. Segman, R. Ebstein, M. Katz, L. Nebamov, Y. Cohen, M. Avnon, B. Lerer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

760

S-50-1 - Ultra-rapid opioid detoxification using narcotic antagonists

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

761

S-50-2 - Naltrexone: Critical review of studies in animals for their relevance to alcoholism treatment

J.H. Woods, K. Williams, J. Vivian, D. Jewett, E. Pakarinen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

762

S-50-3 - Narcotic antagonists in the treatment of alcoholism

C. O’Brien, J. Volpicelli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

763

S-50-4 - Use of narcotic antagonist in treating opioid addiction

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

764

S-50-5 - European experience with narcotic antagonists in the treatment of opioids and alcohol dependence

E. Tempesta, P. Mannelli

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

765

S-50-6 - Endogenous opioids and experimental addiction

J.M. Van Ree, M.A.F.M. Gerrits

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

766

S-50-7 - Uses of narcotic antagonists in the treatment of addiction

H.D. Kleber, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

767

S-51-1 - Modulation of cerebral Monoamine release by Mao inhibitors

J. Finberg, I. Lamensdorff, I. Kopin, M. Youdim

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

768

S-51-2 - Potentials of MAO-A and B inhibitors in the clinic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

769

S-51-3 - The rima moclobemide: More than an effective antidepressant?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

770

S-51-4 - Pharmacological profile of befloxatone, a reversible and selective MAO-A inhibitor

O. Curet, D. Caille, J. Benavides, H. Depoortere, B. Scatton

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

771

S-51-5 - Clinical pharmacology profile of befloxatone

P. Rosenzweig, J.L. Pinquier, G. Durrieu, O. Curet, C. Dubruc

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

772

S-52-1 - Pet-studies on the dopamine system in vivo

L. Farde, N. Ginovart, C. Halldin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

773

S-52-2 - Imaging of the brain serotonin system

T. Suhara, Y. Sudo, H. Fukuda, Y. Okubo, O. Inoue, K. Suzuki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

774

S-52-3 - Mapping the future in schizophrenia

Nancy C. Andreasen, Daniel S. O’Leary, Stephan Arndt, Ted Cizadlo, Richard Hichwa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

775

S-52-4 - Applications of H215O pet activation studies in normal and disordered brain function

Brendan T. O’Sullivan, John D. Watson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

776

S-52-5 - High temporal resolution functional brain electrical activity mapping in psychiatry

R.B. Silberstein

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

777

S-53-1 - Quality of life in depression — How should it be measured?

H. Katschnig, C. Simhandl, M. Serim, B. Subasi, A. Zoghlami, K. Jaidhauser, B. Kramer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

778

S-53-2 - Development of the who quality of life assessment instrument (WHOQOL) and its application in assessing the recovery from depression

H. Herrman, B. Murphy, S. Freidin, N. Allen

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

779

S-53-3 - Basic issues in quality of life (QL) assessment in psychiatry — The leap from QL to health economics

A.G. Awad, L.P.N. Voruganti, R.J. Heslegrave

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

780

S-53-4 - Quality of life and quality of care in severely psychotic patients

M. Schmitz, S. Rudas

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

781

S-53-5 - Are single figure generic quality of life measures sensitive to change with mental health interventions?

T.J. Stedman, J.L. Welham

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

782

S-54-1 - Activity of noradrenegic locus coeruleus (LC) neurons in monkey during performance of an attentional task

G. Aston-Jones, J. Rajkowski, P. Kubiak, S. Ivanova

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

783

S-54-2 - The integration of intrinsic properties and synaptic inputs in locus coeruleus

J.T. Williams, M. Ishimatsu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

784

S-54-3 - Electrical and dye coupling in locus coeruleus neurones during postnatal development

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

785

S-54-4 - Neurotransmitter modulation of coupling in locus coeruleus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

786

S-54-5 - Experimental studies of the functions of central noradrenaline in animals and humans

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

787

S-55-1 - Familial transmission of alcoholism and anxiety disorders

K.R. Merikangas, D. Stevens, B. Fenton, N. Risch

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

788

S-55-2 - Gender differences in the genetic contribution to alcoholism risk: Findings from the Australian twin panel

A.C. Heath, W.S. Slutske, P.A. Madden, N.G. Martin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

789

S-55-3 - Association between alcoholism and genetic markers

W. Maier, F.C. Delmo, D. Wildenauer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

790

S-55-4 - Effects of alcohol dehydrogenase genotype on alcohol pharmacokinetics: A model system for QTL analysis

N.G. Martin, B. Nightingale, J.B. Whitfield

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

791

S-56-1 - The neurodevelopmental hypothesis of schizophrenia: A critical clinical perspective

D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

792

S-56-2 - Schizophrenia: A neurodevelopmental and progressive disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

793

S-56-3 - Neurodevelopmental disturbance in schizophrenia as the origin of later, active disease?

J.L. Waddington, E. O’Callaghan, P. Buckley, H.A. Youssef, C. Larkin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 272 KB

english, 1996

794

S-56-4 - Neural cell adhesion molecules and the developmental hypothesis of schizophrenia

L.K. Srivastava, D. Barbeau, J.J. Liang, G. Flores, R. Quirion

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

795

S-56-5 - Neuroimaging in schizophrenia: From acute to chronic illness

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

796

P-15-1 - Long-term safety of risperidone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

797

P-15-2 - Weight gain and long term clozapine efficiency

I. Jalenques, I. Tauveron, E. Albuisson, V. Audy

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 140 KB

english, 1996

798

P-15-3 - Megacolon associated with longterm neuroleptic medication

H. Kazamatsuri, Y. Igarashi, Y. Mizutani, H. Habu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 277 KB

english, 1996

799

P-15-4 - Relationship between akathisia and parkinsonism in schizophrenic patients who receive neuroleptics

E. Brunner, H.A. Ortega-Soto

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

800

P-15-5 - Comparison of extrapyramidal syndromes between olanzapine and placebo in schizophrenia

J. Street, M. Dellva, R. Tamura, T. Sanger, G. Tollefson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

801

P-15-6 - ‘Seroquel’ (ICI 204,636) does not differ from placebo in the incidence of eps or effect on plasma prolactin

W.W. Hong, L.A. Arvanitis, B.G. Miller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

802

P-15-7 - Respiratory dyskinesia: A prevalence study using computer analysis of spirograph data

T. Nishikawa, M. Tanaka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 293 KB

english, 1996

803

P-15-8 - The incidence of neutropenia and agranulocytosis in patients treated with clozapine in the UK and Ireland

K. Atkin, F. Kendall, H. Freeman, H. Lieberman, D. O’Sullivan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

804

P-15-9 - Treatment of the neuroleptic malignant syndrome by electroconvulsive therapy

Dagmar Seifertová

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

805

P-15-10 - Considerations about neuroleptics' use: Past, present and future

A. Moroni, N. Kaufmann, A. Zanobio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

806

P-15-11 - Teaching schizophrenic patients about their depot neuroleptic medication

M. Peet, G. Turpin, T. Nielson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

807

P-15-12 - Effects of clozapine on cognitive performance in schizophrenia. A clinical study

S. Totic, D. Marinkovic, B. Acimovic, T. Babinski, V.R. Paunovic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 156 KB

english, 1996

808

P-15-13 - Genetic-epidemiology of schizophrenia: A pilot study

I. Timotijević, O. Marinković

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

809

P-15-14 - Intact 5-HT2A receptor gene in schizophrenia

K. Ohara, T. Ishigaki, D.-W. Xie, Y. Nakamura, K. Tani, K. Miyasato, K. Ohara

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

810

P-15-15 - Inositol-lipid signalling system in blood platelets of schizophrenic patients

D. Řípová, V. Nĕmcová, A. Strunecká, C. Höschl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

811

P-15-16 - Changes of platelet serotonin-2 receptors in chronic neuroleptic-treated schizophrenia

W.C. Liu, Y.H. Chou, W.K. Chen, P.M. Chen, W.J. Tsai, J.F. Liao

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

812

P-15-17 - Dopamine D2-family receptors in human postmortem brain: Comparison of normals and schizophrenics

R.A. Lahti, R.C. Roberts, R.R. Conley, C.A. Tamminga

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

813

P-15-18 - An association study between atypical psychosis and dopamine D2 receptor gene

I. Sakai, H. Yoneda, Y. Inayama, Y. Nonomura, Y. Kono, R. Takahata, J. Koh, H. Toyoda, Y. Inada, A. Himei, T. Sakai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 258 KB

english, 1996

814

P-15-19 - Anticipation and triplet repeats in schizophrenia

A. Imamura, Y. Okzaki, M. Hayashida, T. Tsujita, N. Niikawa, Y. Nakane, S. Matsumoto

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 129 KB

english, 1996

815

P-15-20 - Association of neurotrophin-3 gene variant with severe forms of schizophrenia

S. Nanko, M. Hattori

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 129 KB

english, 1996

816

P-15-21 - Chronic fluvoxamine treatment reduces platelet MAO activity in medicated chronic schizophrenics

Henry Silver, Natan Odnopozov, Nabil Jahjahl, Igor Barash

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 129 KB

english, 1996

817

P-15-22 - Monoamine metabolism in acute methamphetamine psychosis-comparison with schizophrenia

Y. Igarashi, M. Fukuda, N. Horita, H. Fujimori, H. Kazamatsuri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 129 KB

english, 1996

818

P-15-23 - Disturbances of one-carbon metabolism in schizophrenia

B. Regland, C.G. Gottfries, B. Grenfeldt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

819

P-15-24 - Impaired LTP of recurrent inhibition onto CA 1 hippocampal pyramidal cells as a cellular basis of schizophrenia

H. Grunze, D. Rainnie, E. Hearn, E. Barkai, M. Hasselmo, R. McCarley, R. Greene

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

820

P-15-25 - Changes of plasma prolactin, ACTH, cortisol & clinical symptoms after ECT in schizophrenia

H.W. Woo, W.J. Lim, J.W. Kim, S.Y. Nam

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

821

P-16-1 - Hydrocortisone-induced corticotropin responses during the menstrual cycle

F. Burnett, J.H. Thakore, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

822

P-16-2 - Effects of metyrapone treatment upon hormonal secretion and sleep

H. Jahn, K. Wiedemann, A. Steiger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

823

P-16-3 - Growth hormone-releasing peptide stimulates growth hormone, ACTH and cortisol secretion and sleep in man

A. Steiger, R-M. Frieboes, H. Murck, T. Schier, F. Holsboer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

824

P-16-4 - Effect of fluoxetine on dexamethasone induced growth hormone release in depression

J.H. Thakore, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

825

P-16-5 - Effect of serum cholesterol levels on neuroendocrine responses in healthy subjects

T. Terao, R. Yoshimura, O. Ohmori, N. Takahashi, T. Takano, T. Suzuki, K. Abe, N. Iwata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

826

P-16-6 - The paroxetine challenge test for in vivo evaluation of serotonin function in man

C. Reist, L. Albers, D. Helmeste, S.W. Tang

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

827

P-16-7 - Adrenergic nervous systems affect the clonidine challenge test

M. Kubota, M. Atobe, N. Nemoto, A. Suwabe, M. Nakagawara, T. Kariya

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

828

P-16-8 - Ipsapirone modulates clonidine challenge test in rats

M. Niwa, M. Kubota, M. Atobe, K. Kobayashi, M. Nakagawara, T. Kariya

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 278 KB

english, 1996

829

P-16-9 - Neuroendocrine responses to ipsapirone in patients with panic and obsessive compulsive disorder

T.R. Norman, M. Apostolopoulos, E. Barson, G.D. Burrows, A. Cockram, F.K. Judd

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

830

P-16-10 - The role of the serotonergic system on nocturnal cortisol and prolactin secretion in healthy humans

P.J. Nathan, T.R. Norman, G.D. Burrows

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

831

P-17-1 - Positron emission tomography in schizophrenics treated with sertindole and haloperidol

M.S. Buchsbaum, E. Hazlett, M. Haznedar

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

832

P-17-2 - Sustained 5HT2A receptor occupancy of ziprasidone using pet ligand 18F setoperone in healthy volunteers

A. Fischman, S.A. Williams, C. Drury, P. Etienne, R. Rubin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

833

P-17-3 - 99TC-HMPAO-SPECT in bulimia nervosa: A pre and post fluoxetine treatment study

A. Chinchilla, J.J. Padín, M. Vega, A. Cebollada, C. Lancha

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

834

P-17-4 - Qualitative analsis of cerebral images in schizophrenia patients: A 99Tc-HMPAO SPECT study

A. Cebollada, M. Vega, J.J. Padín, A. Chinchilla, C. Lancha

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

835

P-17-5 - Regional cerebral perfusion by Tc-99m HMPAO SPECT before and after tacrine in alzheimer's disease

R. Tourtauchaux, I. Jalenques, D. Mestas, J. Maublant

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

836

P-17-6 - A study of regional cerebral blood flow with 99TC-HMPAO-SPECT in eating disorders

M. Vega, A. Chinchilla, J.J. Padín, A. Cebollada, C. Lancha

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

837

P-17-7 - Dopamine and serotonin receptor occupancy by atypical antipsychotic drugs In vivo

Y. Takahashi, I. Kusumi, T. Ishikane, T. Koyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

838

P-17-8 - Optimized analysis of the D2 dopamine receptor occupancy by image fusion of corresponding I-123 IBZM-spect and MR-DATA

T. Mager, S. Dresel, K. Tatsch, T. Pfluger, H.J. Möller, K. Hahn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

839

P-17-9 - Neuroleptic dose related D2 receptor occupancy measured by IBZM spect

R. Coppola, M.B. Knable, A. Heinz, J. Gorey, D.R. Weinberger

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

840

P-17-10 - Pharmaco EEG effects of S(+) DN-2327 enantiomer and DN-2327 racemate

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

841

P-17-11 - Quantitative electroencephalography in primary dysthymia

A. Ravindran, V. Knott, Y. Charbonneau

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

842

P-17-12 - EEG coherence analysis shows hypofrontality in schizophrenic patients

J. Tauscher, P. Rappelsberger, A. Neumeister, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

843

P-17-13 - Acute CEEG modifications after clozapine and haloperidol administration in schizophrenics

G.F. Marchesi, B. Nardi, G. Pannelli, G. Santone, P. Ianni, M. Brandoni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

844

P-17-14 - EEG mapping longitudinal evaluation of patients affected by schizophreniform disorder

G.F. Marchesi, B. Nardi, G. Pannelli, F. Poletti, C. Pierini, S. Biagiotti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

845

P-17-15 - Difference of processing among parts-of-speech using event-related potentials

A. Takashima, K. Ohta, M. Yoshino, T. Ohkura, K. Hara, E. Matsushima, M. Toru

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

846

P-17-16 - Auditory P300 in depression with silent cerebral infarction

I. Yanai, Y. Otagaki, Y. Touhouda, T. Fujikawa, M. Osada, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

847

P-17-17 - Contextual effects and repetition effects on N400 and late positive component

K. Ohta, A. Takashima, M. Yoshino, T. Ohkura, K. Hara, E. Matsushima, M. Toru

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 295 KB

english, 1996

848

P-17-18 - Effects of dopamine related drugs on event-related potentials and its relation to the law of initial value

C. Ogura, N. Nishimura, M. Urasaki, I. Ota

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

849

P-17-19 - Neuroleptic treatment and MRI brain changes in schizophrenia

M. Jarema, M. Choma, E. Poniatowska, R. Krawczyk

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

850

P-17-20 - Discrimination among schizophrenic, depressive and normal control groups using neurophysiological tests

S. Takahashi, E. Tanabe, M.L. Xia, T. Sakai, M. Matsuura, T. Kojima, E. Matsushima, S. Obayashi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

851

P-17-21 - Synaptic loss in the thalamus of schizophrenics

K. Blennow, N. Bogdanovic, P. Davidsson, R. Ekman, C.G. Gottfries, B. Grenfeldt, I. Karlsson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

852

P-17-22 - Loss of cerebral asymmetry in familial schizophrenia — A volumetric study using unbiased stereology

T. Sharma, S.W.L. Lewis, T. Sigmundsson, E. Lancaster, P. Barta, G. Pearlson, H. Gurling, R.M.M. Murray

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

853

P-18-1 - Electroconvulsive therapy in elderly depressed patients

G.N. Papadimitriou, Y.G. Papakostas, I.M. Zervas, G.I. Kanatas, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

854

P-18-2 - Cognitive effects of ECT after TRH administration

I.M. Zervas, A. Pehlivanidis, Y.G. Papakostas, G.N. Papadimitriou, M. Markianos, C.N. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

855

P-18-3 - Anaesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone: A controlled randomized trial

Shoshana Saffer, Michael Berk, Alexander J. O’Neill-Kerr

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

856

P-18-4 - The influence of ect on olfactory memory

Pinkhas Sirota, Tanya Mosheva

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

857

P-18-5 - NGF plasma levels in psychiatric patients treated with ECT: Results at IV and VIII ECT

G. Bersani, L. Aloe, A. Iannitelli, P. Maselli, F. Angelucci, E. Alleva, P. Orsi, P. Pancheri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

858

P-18-6 - Prolactin and cortisol release during ect are not influenced by pretreatment with the serotonin receptor agonist sumatriptan

J. Hatzimanolis, L. Lykouras, M. Markianos, C. Stefanis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

859

P-18-7 - Neurotransmitter releasing response after single and repeated electroconvulsive shock treatment

K. Yoshida, H. Higuchi, M. Kamata, M. Yoshimoto, Y. Hishikawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

860

P-18-8 - Modulation by nifedipine of ECS action on second messenger and protein kinase C-related effects

I. Nalepa, M. Kowalska, G. Kreiner, J. Vetulani

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

861

P-18-9 - Repeated electroconvulsive shock-induced changes of serotonin responses in hippocampal CA1

K. Ishihara, T. Amano, H. Hayakawa, S. Yamawaki, M. Sasa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

862

P-18-10 - Effect of substance abuse on the course of Bipolar Disorder

D. Dunner, J. Feinman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

863

P-18-11 - Comparison between early- and late-onset rapid cycling affective disorders. -Clinical course and response to pharmacotherapy

Y. Fujiwara, T. Honda, S. Aoki, S. Kuroda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 280 KB

english, 1996

864

P-18-12 - Lithium appears to inhibit recovery from the depressive phase of bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

865

P-18-13 - Fluoxetine-induced, rapid cycling mania in an adolescent

Brian A. Robertson, Ashley Robins

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

866

P-18-14 - Relationship between late-onset mania and silent cerebral infarction

T. Fujikawa, S. Yamawaki, Y. Touhouda

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

867

P-18-15 - Linkage analyses of chromosomes 6 (pter-p22), 16, 18 (pericentromeric) and 21 (q22.3) in bipolar disorder pedigrees

P. Mitchell, L. Adams, J. Kwok, J. Salmon, J. Donald, A. Rosso, P. Schofield

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

868

P-18-16 - Increased levels of Gαs in platelets of euthymic bipolar affective disorder patients

P. Mitchell, H.K. Manji, G. Chen, L. Jolkovsky, E. Smith-Jackson, K. Denicoff, M. Schmidt, W.Z. Potter

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

869

P-18-17 - Effects of the calcium antagonist diltiazem on the amphetamine model of mania in humans

J.E. Fabian, P.H. Silverstone

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

870

P-18-18 - Lamotrigine may limit pathological excitation by modulating sodium and potassium currents

H. Grunze, J. v. Wegerer, J. Walden

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

871

P-18-19 - Effects of lithium and carbamazepine on serum calcium concentrations in neuropsychiatric patients

T. Shinkai, R. Yoshimura, T. Terao, K. Abe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

872

P-18-20 - Inhibitory effects of lithium ion intracellular calcium ion movements

Y. Okamoto, A. Kagaya, H. Zenshou, M. Shimizu, A. Nishida, S. Yamawaki

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

873

P-18-21 - Lithium: cAMP synthesis and serotonin release in the brain of freely moving rats

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

874

P-18-22 - New anticonvulsive compounds of sulfonamide derivatives line

H. Zlenko, V. Mamchur, L. Kasjan, O. Krasnovskaja, A. Kasyan, V. Butchenko, H. Demchenko, V. Opryshko

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

875

P-18-23 - Convulsive and anticonvulsive influence of some L-asparagic acid derivatives

M. Kamri, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

876

P-18-24 - The effects of Zonisamide and other antiepileptic drugs when administered incombination on the seizure-susceptible EI mouse

M. Nomaguchi, I. Nagatomo, Y. Akasaki, F. Nagase, M. Uchida, M. Tgakigawa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

877

P-19-1 - Flesinoxan improves cognition in the healthy elderly

J. Van Harten, M. Olff, K. Wesnes, W. Strobel

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

878

P-19-2 - Effects of benzodiazepines on conscious and automatic memory processes

J.M. Danion, P. Vidailhet, M. Kazès, F. Kauffmann-Muller, D. Grangé

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 158 KB

english, 1996

879

P-19-3 - Impairment of fine short-term memory mechanisms with some neurotropic drugs

N.S. Sapronov, I.I. Stepanov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

880

P-19-4 - Nutrient presentation of cognitive and memory performances

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

881

P-19-5 - Transient global amnesia-possible aetiopathogenetic mechanisms

D. Bugarski-Kirola, C. Prokopljevic, M. Kovacevic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

882

P-19-6 - Ginkgo biloba in the treatment of senile dementia

W. Jian Yi, D. Sinbon, P. Shuching, L. Bolan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 145 KB

english, 1996

883

P-19-7 - Treatment with “Deproteinized calves' blood extract” in mild and moderate Alzheimer's

R. Nivataphand, W. Sangsanguan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 146 KB

english, 1996

884

P-19-8 - Adenylyl cyclase immunoreactivity in dementia of the Alzheimer type

M. Yamamoto, H. Ozawa, T. Saito, S. Hatta, P. Riederer, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 288 KB

english, 1996

885

P-19-9 - The study of differentially expressed molecules in Alzheimer's disease brain

M. Yamada, E. Richelson, M. Yamada

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

886

P-19-10 - A connectionist model of semantic degradation in Alzheimer's disease

T.M. Gale, R.J. Frank, D.J. Done, S.P. Hunt

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

887

P-19-11 - Calcium mobilizing action of amyloid beta-protein in human platelets

H. Ishikawa, H. Ozawa, S. Shichinohe, T. Saito, H. Takemura, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

888

P-19-12 - The level of glutamine synthetase in Alzheimer's disease brain

G. Burbaeva, I. Boksha, E. Tereshkina, V. Monakhov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

889

P-19-13 - The influence of testenate on the brain functional condition of aging

V. Koldunov, E. Topka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 157 KB

english, 1996

890

P-19-14 - Neurotropic effect of testenate and tocopherol in androgen insufficiency

E. Topka, V. Koldunov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

891

P-19-15 - Efficacy of indeloxazine hydrochioride, a cerebral activator, in cerebral ischemic patients

K.H. Lee, M.H. Kim, J.K. Roh

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

892

P-19-16 - Pharmacological profile of OPC-14523 (2): Effects on learning and memory impairment

M. Nakai, K. Tottori, T. Kikuchi, Y. Uwahodo, T. Miwa, Y. Oshiro, S. Morita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

893

P-19-17 - Further characterization of effects of dynorphin on galanin-induced amnesia

M. Ukai, M. Miura, T. Kameyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

894

P-19-18 - Differential effect of novel and reference antipsychotics on place navigation of rats in morris water maze

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

895

P-19-19 - Comparative effects of S9977-2 vs tacrine on passive avoidance learning

X.A. Alvarez, R. Zas, M. García, E. Polo, D. Guez, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

896

P-19-20 - The influence of fluoxetine on memory, anxiolytic activity and locomotor function in rats

E. Nowakowska, A. Chodera, K. Kus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

897

P-19-21 - Pharmacological profile of OPC-14523 (1): A novel sigma and 5-HT1A receptor agonist

K. Tottori, T. Kikuchi, Y. Uwahodo, M. Nakai, T. Miwa, Y. Oshiro, S. Morita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

898

P-19-22 - Functional differences of the cerebral cortex in short-term memory and attention in rats

T. Yamamoto, N. Yukuhiro, S. Watanabe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

899

P-19-23 - Distribution of glial fibrillary acidic protein in the cochlear nucleus of adult and aged rats

I. Jalenques, E. Albuisson, G. Despres, R. Romand

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

900

P-19-24 - Changes of calbindin & parvalbumin immuno-reactive neurons in the brain of aging rats

H.W. Woo, W.J. Lim

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

901

P-19-25 - Changes of neuropeptide immunoreactive neurons in the cerebral cortex of aging rats

H.W. Woo, W.J. Lim, K.W. Yeun, I.G. Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

902

P-19-26 - Apparent lack of regulation of muscarinic receptors on rat brain synaptosomes

M. Geurts, E. Hermans, J.M. Maloteaux

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

903

P-19-27 - Effect of dynorphin A (1–13) on decrease in acetylcholine release induced by carbachol in rats

M. Hiramatsu, H. Murasawa, H. Mori, T. Kameyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

904

P-19-28 - Enhancement of acetylcholine release by SA4503, a novel σ1 agonist, in rat brain

T. Kobayashi, K. Matsuno, K. Nakata, S. Mita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

905

P-19-29 - Ameliorating effect of SA4503, a novel σ1 agonist, on memory impairments in rats

K. Matsuno, T. Senda, M. Nakazawa, K. Okamoto, S. Mita

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 292 KB

english, 1996

906

P-19-30 - Effect of postmortem interval on phospholipid and fatty acid composition in the rat brain

D. Řípová, V. Němcová, C. Höschl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

907

P-19-31 - Effect of “Kangenkaryu” on cerebral blood flow and gene expression in rat

K. Sugaya, M. Gallagher, M. McKinney

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

908

P-19-32 - Prevention of Zinc neurotoxicity with a Zinc chelator

M. Cuajungco, G.J. Lees

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

909

P-19-33 - Beta-25–35 induces neurotoxicity by altering calcium homeostasis in cerebellar granule cells

A. Scorziello, O. Meucci, T. Florio, M. Salmona, G. Forloni, G. Schettini

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

910

P-19-34 - Spermine neurotoxicity in the hippocampus: A behavioural and neurochemical study

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

911

P-19-35 - Effects of anapsos on the activity of SOD in an animal model of neurodegeneration

L. Fernández-Novoa, A. Franco-Maside, X.A. Alvarez, B. Vecino, J. Díaz, J.M. Sempere, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

912

P-19-36 - Effects of anapsos on brain histamine and IL-1β levels in an animal model of neurodegeneration

A. Franco-Maside, L. Fernández-Novoa, X.A. Alvarez, B. Vecino, J. Díaz, J.M. Sempere, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

913

P-19-37 - Effects of anapsos on longevity, behavior and brain neurochemistry in mice

X.A. Alvarez, R. Zas, R. Lagares, A. Franco, L. Fernández-Novoa, J. Díaz, J.M. Sempere, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

914

P-19-38 - Electron microscopical study on rat dentate gyrus following chronic toluene exposure

K. Fukui, H. Utsumi, Y. Tamada, Y. Ibata, T. Nakajima

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

915

P-19-39 - Brain neurotoxic lesions in rats: Study of the neuroprotective effects of CDP-Choline

J.J. Miguel-Hidalgo, X.A. Alvarez, R. Lagares, A. Franco, L. Fernández, R. Cacabelos

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

916

P-19-40 - Cystatin C and apolipoprotein E immunoreactivity in CA1 neurons in ischemic gerbil hippocampus

H. Ishimaru, K. Ishikawa, Y. Ohe, A. Takahashi, Y. Ikarashi, Y. Maruyama

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

917

P-19-41 - MAO-B enzyme and I2-imidazoline receptor binding sites after excitotoxic lesions of rat hippocampus

T.C.D. Burazin, W.J. Louis, A.L. Gundlach

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

918

P-19-42 - Studies on lithium-pilocarpine neurotoxicity in rats

B. George, S.K. Kulkarni

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

919

P-19-43 - Neuroprotective effects of the pyrrolopyrimidine U-104067F against 3-acetylpyridin neurotoxicity

V. Sethy, H. Wu, J. Oostveen, E. Hall

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

920

P-19-44 - Effect of adrenoceptor blockade on cortical c-fos mRNA after minimal cortical lesion

P.J. Shen, A.L. Gundlach

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 290 KB

english, 1996

921

P-19-45 - Calcium channel biocker felodipine and motor activity of spinal cord injured rabbits

P. Draganic, A. Simonic

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

922

P-20-1 - Cytochrome P450 inhibition: Interactions with calcium and serotonin transporter

S.W. Tang, D.M. Helmeste, R. Vu

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

923

P-20-2 - Do PGI2 derivatives block the extraordinary increase of neuronal Ca2+ levels?

I. Hara, Y. Watanabe, H. Araki, Y. Karasawa, T. Shibuya

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

924

P-20-3 - Effect of vasopressine on C1-uptake in cultured astroglis

L. Katay, L. Latzkovits, C.S. Torday, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 154 KB

english, 1996

925

P-20-4 - Effects of a long-term treatment with carbamazepine on catecholamine secretion in adrenal medullary cells

R. Yoshimura, N. Yanagihara, T. Terao, K. Abe, F. Izumi

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 304 KB

english, 1996

926

P-20-5 - Effects of imidazoline drugs on early response gene activity in brain, kidney and adrenal gland

A.L. Gundlach, T.C.D. Burazin, W.J. Louis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

927

P-20-6 - [3H]-pramipexole receptor binding studies reveal D3 receptors in basal ganglia/mesolimbic areas

M. Camacho-Ochoa, E. Walker, M. Piercey

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

928

P-20-7 - Participation of Vitamin B12 in the regulation of neuronal adenylyl cyclase signal transduction

S. Hatta, M. Watanabe, H. Ikeda, H. Ozawa, T. Saito, N. Takahata

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 166 KB

english, 1996

929

P-20-8 - Role of G-protein in the control of neurotensin receptor internalization

E. Hermans, J.M. Maloteaux

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 298 KB

english, 1996

930

P-20-9 - Immunohistochemical localization of neurotrophin receptors in the adult rat ventral cochlear nucleus

A. Burette, I. Jalenques, R. Romand

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

931

P-20-10 - Distribution of TRK receptors in the adult dorsal cochlear nucleus of the rat

A. Burette, I. Jalenques, R. Romand

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

932

P-20-11 - Effects of divalent cations and nucleotides on the binding of [3H]8-OH-DPAT in human brain

L. Palego, A. Rossi, A. Batistini, M. Fancelli, F. Vergata, G. Giannaccini, D. Marazziti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

933

P-20-12 - The binding of some psychotropic drugs at the molecularly cloned human histamine H1 receptor expressed by CHO cells

M. Yamada, S. Martinez, Mi Yamada, E. Richelson

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

934

P-20-13 - Receptors of chromatin for drug discovery

B.A. Reikhardt, O.G. Kulikova, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

935

P-20-14 - Involvement of the GABAA receptor gamma3 subunit in a behavioral effect of nitrous oxide (N2O)

R.M. Quock, N. Fulkerson, E.M. Branda, J.D. Bourgault, E.A. Ellenberger, J.L. Mueller, L.K. Vaughn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

936

P-20-15 - The effect of sulpiride on NMDA receptor mRNA levels in rat whole brain

H. Toyoda, R. Takahata, Y. Inayama, J. Sakai, M. Fukai, H. Yoneda, T. Sakai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

937

P-20-16 - Autoradiography of Na+-dependent L-glutamate transport in the rat brain

G.L. Blume, L.S. Dias, A. Bested, L. Bohart, V.J. Balcar

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

938

P-21-1 - Changes of the lymphocyte subset in major depressive disorder and schizophrenia

D.B. Park, S.W. Kim, B.S. Kee, J.K. Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

939

P-21-2 - A study on the relationship between circulating-NK-cell and personality characteristics in neurotic patients

D.B. Park, C.H. Lee, J.K. Lee, K.H. Lee

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

940

P-21-3 - Concurrent treatment with verapamil decreases immune response to cannabimimetic anandamide

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

941

P-22-1 - Patients selection in clinical trials with antipsychotics

M. Hummer, R. Huber, T. Walch, W.W. Fleischhacker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

942

P-22-2 - Typical antipsychotics: The threshold doses strategy

H.A. Ortega-Soto, E. Brunner, R. Apiquian, M.P. de la Torre, R.E. Ulloa

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

943

P-22-3 - Interrater reliability and the PANSS — What does it tell us about efficacy in neuroleptic trials?

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 284 KB

english, 1996

944

P-22-4 - Effects of conventional and atypical antipsychotic agents on cognitive function in schizophrenia

Bernd Gallhofer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

945

P-22-5 - Cognitive functioning in schizophrenia: A trial of risperidone versus haloperidol

J. Addington, D. Addington

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

946

P-22-6 - Twenty years of clinical experience with the use of clozapine in severe psychotic patients

J. Ciprian-Ollivier, M. Cetkovich-Bakmas, J. Albin, G. Vázquez

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

947

P-22-7 - Treatment of schizophrenia and schizoaffetive disorder with a combination of clozapine and lithium

S.A. Bender, J.R. Wolstein, K. Ortmann, J.U. Blanke, H.J. Paulus

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

948

P-22-8 - The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 281 KB

english, 1996

949

P-22-9 - The efficacy and safety of two fixed doses of ziprasidone in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

950

P-22-10 - Prediction of clinical efficacy of antipsychotic bromperidol, nemonapride, mosapramine using multivariate analysis of variance

C. Ogura, I. Ohta, H. Utsumi, N. Nishimura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

951

P-22-11 - Large, multicenter, open trial of risperidone in schizophrenia

D.V. Jeste, M. Klausner, M. Brecher, C. Clyde, R. Jones

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

952

P-22-12 - Effectiveness of glutamate agonist on negative symptoms of schizophrenia

A. Lenzi, S. Raffaelli, I. Bianco, V. Milazzo, D. Marazziti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

953

P-22-13 - Long term-treatment of a new atypical neuroleptic, SM-9018 on patients with schizophrenia

M. Murasaki, S. Miura

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 144 KB

english, 1996

954

P-22-14 - Seroquel (ICI 204636): An atypical antipsychotic — Results from phase III

D.J. King, C.G.G. Link

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 106 KB

english, 1996

955

P-22-15 - Antidepressants in the treatment of depressive syndrome in schizophrenia

M. Jašović-Gašić, G. Nikolić-Balkoski, J. Kunovac, V. Kuzmanović, C. Crnobarić, M. Krsmanović

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 107 KB

english, 1996

956

P-22-16 - Adjuvant sertraline treatment for chronic schizophrenia

J.H. Thakore, C. Berti, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 106 KB

english, 1996

957

P-22-17 - Neuroleptic treatment of psychotic symptoms in HIV seropositive patients

A. Alciati, L. Codazzi, F. Colmegna, C. Chini

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 107 KB

english, 1996

958

L-4-1 - Mechanisms of recurrence and cyclicity in the affective disorders: Implications for treatment

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 135 KB

english, 1996

959

O-23-1 - Functional brain electrical activity mapping during the AX version of the continuous performance task (CPT) in schizophrenia

R.B. Silberstein, P. Line, G. Nield, A. Pipingas, D. Copolov, D. Carter, C. Pantelis, J.J. Wright

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

960

O-23-2 - High temporal resolution functional brain electrical activity mapping in attention deficit hyperactive disorder (ADHD)

M.A. Farrow, R.B. Silberstein, A.A. Sergejew, D.A. Hay, F. Levy, A. Pipingas, F.C. Jarman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

961

O-23-3 - Central effects of 5HT1A-agonists, S-20499 and buspirone: Placebo-controlled, pharmaco-EEG and psychometric studies

B. Saletu, J. Grünberger, P. Anderer, L. Linzmayer, H.V. Semlitsch, G. Zyhlarz

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 136 KB

english, 1996

962

O-23-4 - Quantitative EEG (QEEG) predicts relapse in patients with chronic alcoholism

G. Winterer, B. Klöppel, A. Heinz, M. Ziller, L.G. Schmidt, W.M. Herrmann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

963

O-23-5 - Spect studies during memorization before and after cognitive rehabilitation in cerebral diseases

M. Le Poncin, J.L. Moretti

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

964

O-23-6 - Effects of the releasing hormones GHRH and CRH on the EEG in healthy subjects

Karin Kuhn, Clemenz Haag, Gregor Laakmann, Thomas C. Baghai

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

965

O-23-7 - D2 Dopamine receptor occupancy (IBZM-SPECT) and extrapyramidal symptoms under treatment with risperidone

T. Mager, I. Dähne, S. Dresel, F. Pajonk, K. Tatsch, H.J. Möller

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

966

O-23-8 - A study of early and late onset depression in the elderly using SPECT

N. Prentice, C. Murray, R. O’Carroll, G. Goodwin, K. Ebmeier

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

967

O-23-9 - HMPAO-SPECT in patients with seasonal affective disorder before and after light therapy

A. Neumeister, N. Praschak-Rieder, B. Hesselmann, I. Podreka, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

968

O-23-10 - A spect study of Alzheimer's disease using a cognitive activation paradigm

J. Trollor, P. Sachdev, A. Walker, W. Haindl

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

969

O-24-1 - Type of onset and personality in panic disorder

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

970

O-24-2 - Patient disability in panic disorder

R. Judge, R. Van Dijck, A. Bakker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

971

O-24-3 - The cerebral and abdominal forms of panic disorder and their differential diagnosis

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 285 KB

english, 1996

972

O-24-4 - rCBF in panic disorder and obsessive compulsive disorder

J.V. Lucey, D.C. Costa, G. Busatto, I.M. Marks, P.J. Ell, R.W. Kerwin

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

973

O-24-5 - Developments in the drug treatment of panic disorder

H.G.M. Westenberg

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

974

O-24-6 - Combination of pharmaco- and psychotherapy in the treatment of panic disorder

W.H. Strauss, E. Klieser

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

975

O-24-7 - The effects of CCK-4 in normal individuals: Comparison of panickers and nonpanickers

D. Koszycki, R.M. Zacharko, J.-M. Le Mélledo, J. Bradwejn

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 153 KB

english, 1996

976

O-24-8 - A double-blind comparative study of fluvoxamine and brofaromine in panic disorder patients

I.M. Van Vliet, J.A. Den Boer, B.R. Slaap

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

977

O-24-9 - The long-term efficacy and safety of paroxetine in panic disorder

R. Judge, M. Steiner

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

978

O-25-1 - 5-HT Mediated endocrine responses to D-fenfluramine in hypothyroidism before and after treatment

A.J. Cleare, A.M. McGregor, V. O’Keane

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 147 KB

english, 1996

979

O-25-2 - Effects of nefazodone and paroxetine on 5-Hydroxytryptamine 1A receptor sensitivity

P. Cowen, D. Williamson, P. Sargent, G. Pearson, J. Odontiades

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 148 KB

english, 1996

980

O-25-3 - The combined dexamethasone/CRH-test in rats: Characterization of the HPA axis activity in aging

M. Hatzinger, R. Landgraf, F. Holsboer, I. Neumann

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 291 KB

english, 1996

981

O-25-4 - Thyroid hormone use in euthyroid patients in medicine, psychiatry, and surgery: A review

A.J. Prange Jr.

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

982

O-25-5 - Effect of dieting in women and a low tryptophan diet in rats on prolactin response to m-Chlorophenylpiperazine

M. Franklin, P.J. Cowen, E.M. Clifford, A.E.S. Walsh, R.D. Craven

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

983

O-25-6 - Fast feedback: Evidence for the functioning of type II steroid receptors in depression

J.M. Cooney, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 159 KB

english, 1996

984

O-25-7 - Hormone and catecholamine secretion after administration of moclobemide in depressive in-patients

Gregor Laakmann, Thomas C. Baghai, Clemenz Haag, Karin Kuhn, Udo Becker

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 286 KB

english, 1996

985

O-25-8 - Adrenergic and cholinergic mechanisms in acth-glucocorticoids secretion

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

986

O-25-9 - Neuroendocrine correlates and weight gain during treatment with clozapine

G. Bersani, F. Nordio, F. Pacitti, A. Ricciardi, G. Zisa, P. Pancheri

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

987

O-25-10 - Fenfluramine challenge test in schizophrenia

J. Libiger, L. Motlová, P. Mohr, J. Horáček

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

988

O-25-11 - The effects of naloxone on HPA function in depression

F. Burnett, T. Dinan

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

989

O-26-1 - Depressive psychomotor disturbance, cortisol and dexamethasone

P. Mitchell, D. Hadzi-Pavlovic, G. Parker, I. Hickie, K. Wilhelm, H. Brodaty, P. Boyce

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 142 KB

english, 1996

990

O-26-2 - Validation of the french version of PRIME-MD a primary care evaluation of mental disorder

P. Boyer, J.C. Bisserbe, B. Falissart, R. Spitzer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

991

O-26-3 - The concept of vigilance and aspects of thymoleptic effects in depressive disorder

W.M. Herrmann, G. Winterer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

992

O-26-4 - Psychomotor slowing in depression and schizophrenia

J.J.M. Van Hoof, B.G.C. Sabbe, W. Hulstijn, B.J.M. Jogems-Kosterman, A.J.M. Loonen, F.G. Zitman

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

993

O-26-5 - Dysthymia: Psychopathological profile and treatment correlates

L. Janiri, M. Sarchiapone, A. Hadjichristos, B. Farina, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 149 KB

english, 1996

994

O-26-6 - Comparison between self-evaluation and observer-reported scales in a sample of dysthymic patients

L. Janiri, M. Sarchiapone, B. Farina, R. Rago, E. Vercillo, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 150 KB

english, 1996

995

O-26-7 - Response to placebo in dysthymic disorder different efficacy on depression and anxiety

M. Sarchiapone, L. Janiri, A. Hadjichristos, R. Rago, S. Fontana, S. De Risio

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 287 KB

english, 1996

996

O-26-8 - Severe depression: Recognition and treatment

Y. Lecrubier, J.C. Bisserbe

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

997

O-27-1 - Localization and characterization of serotonin 2A receptor in human brain postmortem

D. Marazziti, L. Palego, A. Rossi, G. Giannaccini, A. Lucacchini, A.G. Naccarato, A. Batistini, F. Vergata, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

998

O-27-2 - CSF anine metabolites in schizophrenia and suicidal behaviour

S.J. Cooper, C.B. Kelly, D.J. King

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

999

O-27-3 - Low CSF - serotonin (5-HT) and suicidality

U. Becker, G. Laakmann, T. Baghai, K. Kuhn, B. Pfeifer, G. Kauert

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

1000

O-27-4 - cAMP signal cascade in postmortem brains of depressives and suicides

H. Ozawa, E. Hashimoto, L. Froelich, T. Saito, N. Takahata, P. Riederer

Journal:

European Neuropsychopharmacology

Year:

1996

Language:

english

File:

PDF, 152 KB

english, 1996

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски